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ABSTRACT-I
Background: Heterogeneous cell populations have previously been described as noisy. However,
recent studies have demonstrated that heterogeneity can be biologically significant. We present
here an approach for rapid and complete identification of heterogeneous cell populations from
high-throughput flow cytometry data. We have developed a novel measure Slope Differentiation
Identification (SDI) using flow cytometry-based protein expression, quantifying the rate of change
in protein expression between two conditions (exponential and stationary phase) of yeast cells, as a
function of cell size or cell granularity.
Results: SDI had superior Gene Ontology enrichment when compared with other approaches such
as k-means clustering and an approach based on the bi-modality of the fluorescence intensity
distribution. Cell populations were also validated using gradient-separation followed by
microscopy, where proteins with high SDI measure showed significant levels of differentiation
between high and low density cells.
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Conclusion: Overall, our approach has identified novel protein expression patterns that differentiate
quiescent and non-quiescent cell populations.
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ABSTRACT-II
Background: With the advent of genomics, there has been a rapid increase in the use of two and onecolor microarrays, used to measure mRNA abundance for the entire genome. Variability in microarray
analysis undermines its utility in identifying the entire subset of differentially expressed mRNAs. Recent
microarray studies have shown that, although it is assumed that variances are constant for every
hybridized spot within a microarray, variances may differ for each biological sample analyzed (Ritchie,
Diyagama et al. 2006).

Another common assumption is that log-intensity values for any given gene

have a Normal distribution. For many datasets, both assumptions have been shown to be incorrect,
resulting in distortions in the significance when testing for differential expression of each gene (BarEven, Paulsson et al. 2006; Wentzell, Karakach et al. 2006).
Approach: To overcome the limitations of existing approaches in identifying significant, differentially
expressed genes, we have developed a novel unsupervised statistical approach called Calibration
Regression Analysis of Microarrays (CRAM) that uses a combination of empirical Bayes and regression
calibration. The main novelty of our approach is the modeling of gene expression variances as a function
of the log-intensity within each sample. Another version was later developed CRAM-GS in which the
association between genes is captured using an adjusted gene correlation measure.
Results: CRAM was compared to four existing approaches for identifying differentially expressed
genes. Performance was based on the ability to identify co-regulated genes in the same Gene Ontology
process. CRAM exhibited a marginal improvement in GO process enrichment compared with the other
approaches. To the original datasets, three more were included in which the later version CRAM-GS,
showed a significant improvement compared to CRAM, suggesting a major additional benefit of
incorporating gene correlations into the model. All versions of CRAM were two orders of magnitude
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faster than the existing approaches. Overall, CRAM provides an adaptive, computationally efficient
approach for accurate identification of differentially expressed genes.
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Chapter 1 – Introduction
1.1 Functional Genomics
Functional genomics, the study of levels of cellular organization in a wholegenome context, was developed as an outgrowth of genomic sequencing projects.
Functional genomics aims to describe gene and protein functions and their interactions,
extending basic concepts of genomics and proteomics by describing dynamic aspects
such as transcription, translation and protein-protein interactions. In summary, functional
genomics can be viewed as a dynamic evolution of the static aspects of genomic
information such as DNA sequences. After the completion of the Human Genome
Project in 2001, an immediate challenge using functional genomics, was to identify the
relations between genes, proteins and the environment that were responsible for the
evolution and functioning of dynamic living systems (Sebastiani, Gussoni et al. 2003).
Our mail goal is to apply quantitative methods in functional genomics in order to better
understand the biological processes involved in many diseases such as cancer, aging and
stem cells. For this purpose, we developed novel high-throughput statistical methods
applied to recent technologies, to study stationary phase cultures in yeast. However, our
methods can also be applicable to other types of experiments.
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1.2 New technologies
Recent advances in technologies, such as microarrays (Fig. 1) and flow cytometry
(Fig. 2), permit researchers to make inferences on dynamic living systems, by observing
relations between thousands of mRNAs or proteins in an organism, under the same
experimental conditions. Massive amounts of data resulting from these technological
advances soon became available, giving rise to another challenge with the analysis of all
this new information. To handle the size and complexity of all the new biological data,
sophisticated and computationally intensive data analysis methods had to be developed.

1.2.1 Microarrays
Since the introduction of microarray technology in the 1990’s, microarray
experiments have been used in molecular biology and in medicine to quantify the
abundance of all mRNA in an organism (Fig. 1), and to attempt to infer the relationship
between mRNA abundance, biological development, disease and physiology (Eisen and
Brown 1999). In the analysis after compiling all the networks and information in a
microarray dataset, lists of candidate genes are generated and are often referred to as
differentially expressed genes. The overall concept involving lists of candidate genes is
the assumption that these genes are interrelated and are part of the same metabolic
pathway.
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Figure 1 - (http://www.dnamicroarray.net/) In spotted microarrays the probes are
oligonucleotides, cDNA, or small fragments of PCR products that correspond to mRNAs.
Each probe contains a different, characteristic sequence that is specific to a different
group of genes under study. These probes are then spotted onto glass substrate to form an
array. One common approach uses an array of fine needles controlled by a robotic arm
that is dipped into wells containing different DNA probes. Each needle then deposits its
probe onto designated locations on the array surface. The probes are then ready to
hybridize with complementary cDNA and cRNA targets derived from experimental or
clinical samples.

One of the challenges in the analysis of microarray data is to integrate and
compare the differential gene lists from multiple experiments for common or unique
underlying biological themes (Yi, Mudunuri et al. 2009). One way to approach this
challenge is by selecting common genes from these gene lists and then subjecting these
genes to enrichment analysis in order to reveal the underlying biology. However, this
3

approach is highly restricted by the limited gene overlaps shared by datasets from
multiple experiments, which could be originated by the complexity of the biological
system itself. On the other hand, small gene overlaps can be the result of sub-optimal
measures of differential expression, and gene list overlaps can be largely improved by the
use of more accurate statistical measures (Shi, Perkins et al. 2008). In the current work,
we introduce a novel statistical method, Calibration Regression Analysis of Microarrays
(CRAM) and some of its variations, in which microarrays are used to optimally model
gene expression in yeast (Saccharomyces cerevisiae).

1.2.2 Flow cytometry
Flow cytometry (Fig. 2) is a well established technique in cell biology, first
developed in the 1970’s for quantifying fluorescence of single cells and other
morphological characteristics, such as size and granularity (Watson 1987). Since its
introduction, the flow cytometer has rapidly become an essential instrument for
biological sciences. In the cytometer, cells are suspended and aspirated into a flow
chamber passing one at a time through a focused laser beam (Fig. 2). When the light
strikes the cell, it is either scattered or absorbed, resulting in quantitative information for
every cell. Since large numbers of cells are analyzed in a short period of time
(>30,000/sec), a large amount of valid information about cell populations is quickly
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obtained (Riley 2002).

Figure 2 (http://www.bioteach.ubc.ca/MolecularBiology/FlowCytometry/flowcytometry.gif)
Detection of fluorescent measurements of cells passing through a laser beam, where
many thousands of cells can be measured, counted and sorted.
Flow data has multiple dimensions leading to far greater computational analysis
and high information content. These large numbers of multi-dimensional data points are
from a statistical point of view, one of flow cytometry’s major strengths (Krutzik, Irish et
al. 2004). In the current work, a novel high-throughput flow cytometry method called
Slope Differentiation Identification (SDI) is developed, based on protein expression
measurements in yeast. Similar to microarrays, the primary goal is to generate
statistically robust lists of candidate genes that reveal distinct populations of cells in
heterogeneous cultures.
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1.2.3 Other Technologies
A more recent technology called RNA-Seq, also called "Whole Transcriptome
Shotgun Sequencing" (WTTS) is a recently developed approach in transcriptomics that
uses deep-sequencing technologies. Studies using RNA-seq have already changed our
view of the extent and complexity of eukaryotic transcriptomes (Wang, Gerstein et al.
2009). This method is also more precise in measuring levels of transcripts and their
isoforms than other methods. RNA-Seq provides researchers with efficient ways to
measure transcriptome data experimentally, allowing them to get information such as
how different alleles of a gene are expressed, detect post-transcriptional mutations or
identifying gene fusions (Maher, Kumar-Sinha et al. 2009). Although we do not analyze
RNA-seq datasets in this dissertation, the same methods developed for microarrays can
be easily extended to this new technology.

1.3 Yeast as a model organism
Yeasts (Saccharomyces cereviciae) are eukaryotic, unicellular, microorganisms
classified in the kingdom Fungi, with about 1,500 species currently described (Kurtzman
2006), although some species with yeast forms may become multicellular through the
formation of a string of connected budding cells known as pseudohyphae. Yeast is also
one of the most researched eukaryotic microorganisms in modern biology, where
researchers have used it to gather information about the biology of eukaryotic cells and
ultimately human biology (Ostergaard, Olsson et al. 2000).
6

Yeast was chosen as a model organism for many reasons. (1) It has low
generation time. The average doubling time of a yeast culture is approximately 2 hours at
30 oC, making it suitable for growing cultures in a short amount of time. (2) Can be
easily manipulated. It can be easily transformed by either altering genes (addition or
deletion) through homologous recombination. The process of generating gene knockout
strains is also largely simplified due to its ability to grow as a haploid. (3) DNA is highly
conserved as an eukaryote. Yeast has similar complex internal cell structures of plants
and animals, without the large amounts of non-coding regions from the DNA in higher
organisms.
Yeast has been used to study cell cycle (Spellman, Sherlock et al. 1998), various
responses to stress (Gasch 2002; Werner-Washburne, Wylie et al. 2002), and entry into
(Gasch, Spellman et al. 2000; Radonjic, Andrau et al. 2005) and exit from stationary
phase (Martinez, Roy et al. 2004; Radonjic, Andrau et al. 2005). In addition, yeast has
been used to study many human diseases such as cancer (Simon, Szankasi et al. 2000;
Marks, Rifkind et al. 2001) as well as the aging process (Ashrafi, Sinclair et al. 1999;
Bitterman, Medvedik et al. 2003; Fabrizio and Longo 2003; McMurray and Gottschling
2004; Piper 2006; Kaeberlein, Burtner et al. 2007).

1.4 Stationary Phase cultures in yeast
Stationary phase is an identifiable component of the culture cycle of
microorganisms that is functionally defined as the time when there is no further net
7

increase in cell number (Fig. 3) (Werner-Washburne 1993). When all external sources
of carbon have been exhausted, cells enter stationary phase.

Figure 3 - Time chart with the different phases leading to stationary phase. Cells are
initially in a glucose-rich media (YPD). In what is known as exponential phase, cells
reproduce rapidly through glucose fermentation until all glucose is totally consumed,
reaching what is known as diauxic shift. During post diauxic shift, cells change their
metabolism to respiration, consuming ethanol as the primary energy source and
reproducing very slowly.
Different phases occur before stationary phase when yeast cells are grown in a glucose
rich medium: exponential phase, diauxic shift and post-diauxic shift. When cells in
exponential phase have exhausted their sources of glucose, the diauxic shift occurs and
they adapt from fermentation to respiration. During the post-diauxic shift cell growth is
highly reduced and after approximately seven days cells enter stationary phase as a result
of carbon starvation (Lillie and Pringle 1980). Stationary phase cultures have very
different properties when compared to exponential phase cultures, such as a rate of
translation 300 times slower (Fuge, Braun et al. 1994) , a rate of transcription three to
five times lower than exponential phase (Paz, Meunier et al. 1999), and are also highly
resistant to stress (Werner-Washburne 1993). As cells exhaust glucose and enter
stationary phase, they differentiate into quiescent (Q) and non-quiescent (NQ) cells (Fig.
4).
8

Figure 4 - Differentiation of quiescent and non-quiescent cell populations. After
performing gradient centrifugation in stationary phase, two types of heterogeneous
populations are observed, an upper (non-quiescent) and a lower band (quiescent).

1.5 Quiescent and non-quiescent cells
Quiescence is the most common cell cycle state on earth (Lewis and Gattie 1991).
Also known as G0, quiescence is critical to the survival of all organisms, where the
efficiency of entrance and exit from quiescence provides a large selective advantage to
microorganisms (Vulic and Kolter 2001) and also long-lived cells such as neurons
(Morrison, Kinoshita et al. 2002) and egg cells (Bevers and Izadyar 2002). Quiescent
cells are also directly involved in tuberculosis (Parrish, Dick et al. 1998), cancer (Gray,
Petsko et al. 2004), stem-cell maintenance (Suda, Arai et al. 2005) , wound healing
(Chang, Yang et al. 2002) and sexual reproduction.
Many phenotypic differences are present between quiescent and non-quiescent
cell populations. Quiescent cells are denser, more refractive, have thicker membranes,
are stress resistant, 90% are daughters and are synchronous in the cell cycle. On the other
hand, non-quiescent cells are lighter, genetically unstable, less than 50% can divide and
9

show high levels of oxidative stress (Allen, Buttner et al. 2006) . In summary,
differences between stationary and exponential phase cultures as well as differences
between quiescent and non-quiescent cell populations make the study of stationary phase
cultures ideal for high-throughput flow cytometry.

1.6 Computational challenges
With the latest developments in microarray and flow cytometry technologies, we
face the ongoing challenges of analyzing large amounts of data, which have been
growing at an exponential rate. In order to achieve quick and reliable results, large
datasets require optimal algorithms. Although sophisticated computational procedures
have been developed in recent years, many of these algorithms require either powerful
computers or long processing time. Moreover, powerful computational algorithms often
provide questionable benefits in detecting additional biological information when
compared to simpler and more efficient ones (Fodor, Tickle et al. 2007). It is our goal to
infer precise biological knowledge and at the same time to be computationally efficient.
Unsupervised models, which are characterized by the lack of a dependent variable,
present some of the main challenges in quantifying biological knowledge, requiring
sophisticated methods to extract biological relationships from experimental data.

First

we generate for all genes a measure of differential expression based on fold change in
intensity (mRNA or protein abundance) and related t-statistics (Table 1).

10

Table 1 - Example of a microarray dataset with log-intensity values. After averaging the
fold change in log-intensity for every gene over all three arrays, an expected log fold
change (exp. FC) for each gene is calculated. After calculating the variance in log fold
change intensity for every gene, the standard deviation is obtained and combined with the
expected log fold change to generate a standard t-statistic.
Gene (ORF)
YAL001C
YAL002W
YAL003W
…
YPR203W

array1
0.03
0.28
0.25
…
‐0.47

array2
0.24
‐0.03
0.17
…
‐0.58

array3 gene var.
0.53
0.063
0.62
0.106
0.46
0.022
…
…
‐0.5
0.003

exp.FC
0.27
0.29
0.29
…
‐0.52

t‐stat
1.06
0.89
1.96
…
‐9.09

Next, differentially expressed genes are selected into gene lists based on ranking the
measure of differential expression (Table 2).

Finally, the significance of gene lists is

evaluated using performance measures. Two common performance measures are often
used:

Gene Ontology (GO) enrichment and gene list overlap (often referred to as

“Concordance”).
Table 2 - Example of microarray dataset in which a gene list is selected. After sorting
genes in descending order by expected log fold change intensity, the top 100 genes (blue)
are selected into a gene list. A similar gene list with the top 100 genes could have been
selected based on sorting genes by the t-statistic.
Gene (ORF)
YIL101C
YML042W
YOL126C
YDR256C
YDR384C
YDR034W‐B
…
YJL016W
YLR136C
YDR545W
YJR019C
YPL147W
YBR294W
YPR184W
…
YNL052W
YCR021C
YBR054W

array1
3.15
2.92
3.31
2.63
3.02
2.32
…
1.46
1.15
0.2
1.06
1.06
0.83
1.3
…
‐2.57
‐3.1
‐3.02

array2
2.86
2.74
2.34
2.62
1.77
2.93
…
1.05
1.13
1.75
1.67
1.23
1.4
1.33
…
‐3.63
‐3.28
‐4.1

array3
gene var.
3.09
0.023
2.9
0.010
2.84
0.235
3.11
0.078
3.2
0.607
2.67
0.094
…
…
1.37
0.046
1.6
0.071
1.88
0.874
1.09
0.118
1.51
0.052
1.57
0.150
1.15
0.009
…
…
‐2.73
0.327
‐2.9
0.036
‐4.64
0.680
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exp.FC
3.03
2.85
2.83
2.79
2.66
2.64
…
1.29
1.29
1.28
1.27
1.27
1.27
1.26
…
‐2.98
‐3.09
‐3.92

t‐stat
19.82
28.92
5.83
9.95
3.42
8.62
…
6.00
4.87
1.37
3.70
5.57
3.27
13.07
…
‐5.21
‐16.27
‐4.75

1.6.1 Gene Ontology enrichment
Gene Ontology (GO) enrichment is a powerful tool to infer biological information.
The basis of GO enrichment derives from measuring the association between gene lists
and known biological knowledge based on Gene Ontology (GO) categories
(GeneOntology ; Boyle 2004). Genes are grouped into GO categories according to
biological process, biological function or cell localization and then GO enrichment of a
gene list is measured based on the number of genes in the list that belong to each GO
category. If the number of genes from a specific GO category is significantly higher than
expected by chance, we say the gene list is enriched in that particular GO category.
More specifically, when a GO category is enriched, it will have a significant p-value,
giving us the confidence that our gene list is detecting groups of genes likely to belong to
the same pathway.

1.6.2 Concordance
Concordance is a measure of reproducibility, often defined as the percentage of
overlap between two gene lists. The assumption is based on statistical measures to
generate independent gene lists in which the overlap is significantly high. Under these
conditions, we can claim that a high overlap is indicative of major biological information
(Lee, Kuo et al. 2000). In other words, when the observed overlap is significantly higher
than the expected overlap (where it is assumed no biological relationship exists), it is
presumed that genes from the two lists describe similar biological patterns.
12

1.6.3 Association
Association can be viewed as an extension of the concept of concordance
applicable to understanding relations between microarrays or between genes. Rank
correlations are often applied as a robust measure of association (Kim, Rha et al. 2004).
When using technical or biological replicates, microarrays with high rank correlation will
provide a high confidence in the gene expression values. Similarly when there is a high
rank correlation between genes, these are more likely to be in the same pathway and
therefore are more likely to be in the same GO category.

1.7 Dissertation overview
In microarray data, differences in log-fluorescence intensity between two
conditions are calculated and then a measure of differential expression is generated and
used to determine differentially expressed genes. Researchers are often interested in the
difference between a test and a control group, and similarly in differences between two
test groups (different treatments). Under such conditions the concept of differential
expression can be further extended for optimal modeling in multi-dimensional datasets
such as flow cytometry, where differences in protein expression are measured.
The goal of this dissertation is to describe novel statistical methods based on
unsupervised models applied to microarray and flow cytometry datasets. These methods
are compared against current methods using exclusively GO enrichment and concordance

13

as performance measures for different datasets. The present work is divided into 5
chapters.
In chapter 2 we present applications of gene list overlaps between lists of
differentially expressed genes and describe some of the main challenges that led the
author to the development of more sophisticated algorithms described in chapter 4. Two
versions of these algorithms that test for differential expression are presented, followed
by the description of an application that combines concordance and GO enrichment for
multiple gene lists. In addition, results from five yeast datasets are shown, together with
a brief discussion. Moreover, we also describe a method for measuring the significance
of multi-dimensional gene list overlaps. Summarizing, chapter 2 aims at describing some
introductory ideas in measuring differential expression without getting into much detail.
In chapter 3, a method is described for rapid and complete identification of
heterogeneous cell populations from high-throughput flow cytometry data. We present a
novel measure, Slope Differentiation Identification (SDI) using flow cytometry-based
protein expression. SDI is used to quantity the rate of change in protein expression
between two conditions (exponential and stationary phase of yeast cells), as a function of
size or granularity of cells (Fig. 5).
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Figure 5 - Scatter plots with slope as a multi-dimensional measure of fold change for two
yeast mutants (CIT1 and ALG14). The X axis (log side-scatter) is related to cell
granularity, whereas triangles represent the corresponding average fold change in logintensity between stationary and exponential phase cultures for different levels of sidescatter. On the left hand side, there is a strong indication that the slope is greater than
zero for the CIT1 yeast mutant strain. On the right hand side, the slope for the ALG14
yeast is very close to zero.
Results showed SDI had superior GO enrichment performance when compared to
other methods such as k-means clustering, average fold change and a method based on
the bi-modality of the fluorescence intensity distribution, referred to as “Visual Two Peak
Classification”. Cell population differences were also validated using a gradientseparation procedure in stationary phase followed by microscopy, where proteins with
high SDI showed significant levels of differentiation between high and low density cells.
In chapter 4 we describe a method that incorporates in a systemic way, the
concepts of concordance and association in order to provide more accurate measures of
differential expression. In order to overcome the limitations presented by current
methods in identifying differentially expressed genes, we developed a novel unsupervised
statistical method called Calibration Regression Analysis of Microarrays (CRAM), in
which empirical Bayes and regression calibration are systemically conjugated. The main
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novelty of CRAM is based on association between microarrays to model variance in gene
expression as a function of the intensity levels within each microarray (Fig. 6).

Figure 6 Scatter plots for each microarray under three different assumptions.
Association is measured between sample log-fold change intensity and predicted log-fold
change intensity from linear regression used by CRAM with remaining microarrays as
explanatory variables. Slopes are a transformation inversely proportional to the variance.
In the top row, gene variances from every sample are assumed constant and equal to each
other (identical slopes). In the middle row, gene variances are assumed constant within
each sample but different between microarrays (each microarray has a different slope).
In the bottom row, gene variances are assumed to change within each microarray sample
(sections within each sample have different slopes).
CRAM gene correlation (CRAM-GC), a more sophisticated version of CRAM
that incorporates gene correlation is presented and compared against other known
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methods. Results using 7 datasets are presented comparing CRAM and CRAM-GC
against other methods. Whereas CRAM showed a marginal improvement when
compared to other methods, CRAM-GC had significantly superior performance.
Chapter 5 summarizes results derived from chapters 2, 3 and 4 and describes
potential improvements for the various methods presented. We show how the concepts
of association and reproducibility are present in all methods. Similarly, these concepts
also appear in gene list performance measures (GO enrichment and concordance),
followed by a discussion of the relationship between variance in gene expression and
concordance. In addition, the benefits of modeling the difference between two
conditions and improvements in modeling multi-dimensional and multiple conditions
using high-throughput flow data are discussed.
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Chapter 2 – Applications
2.1 Microarrays

A DNA microarray is a technology that evolved from Southern blotting and is
highly used in medicine and in molecular biology (Kulesh, Clive et al. 1987).
Microarrays are generally classified into two types: two-channel (often referred to as
cDNA or spotted microarrays) and one-channel (often referred to as oligonucleotide
microarrays). Each microarray is made of thousands of spots of short nucleic acid
polymers. These polymers can be a short section of a gene or other DNA fragment that
are used as probes (usually 100 to 1000 bases long) to hybridize a cDNA (called target)
under very specific conditions. In order to detect hybridization of the probe to its
complementary target sequence, the probe is labeled with a fluorescent marker. Next, the
level of fluorescence is quantified to determine relative mRNA abundance in the target.

2.2 Differentially expressed genes
Gene expression is the process by which information from a gene is used in the
synthesis of a functional gene product. Many steps in the gene expression process can be
modulated, including the transcription, RNA splicing, translation, and post-translational
modification of a protein. Often these products are proteins, but in non-protein coding
genes such as rRNA genes or tRNA genes, the product is a functional RNA (Huttenhofer,
Schattner et al. 2005).
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In a microarray experiment, several replicates (technical or biological) are
generally used to obtain gene-expression measurements for every gene. When technical
replicates are used, all samples originate from the same tissue (humans) or the same
culture (yeast) and are expected to be biologically identical. Thus, differences in
expression can be attributed to measurement error such as array to array variation,
reagent variation and dye incorporation.
When biological replicates are used, samples are expected to be biologically
similar but not biologically identical. One example of biological replicates in yeast is
when each array has a different yeast culture belonging to the same strain, which were
grown following the same strict protocol but nevertheless, have an additional source of
variation (besides all the sources of variation present in technical replicates) which is
attributed to differences between cultures as they grow. We call the data in the
experiments using technical or biological replicates as ‘homogeneous datasets’. In
addition, some experiments have each sample originated from a different strain (yeast
deletion set), which makes biological variability among samples much greater when
compared to biological replicates, and thus an additional source of variability (variability
between strains) is introduced. We call the data in these types of experiments
‘heterogeneous datasets’.
The primary reason for using replicates is to obtain a good level of significance
for a combined measure of differential expression. Once a combined measure of geneexpression is obtained, it is used to generate lists of differentially expressed genes. Lists
of differentially expressed genes are then used to understand the corresponding
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associations between mRNA abundance with development, disease and physiology
(Eisen and Brown 1999).
Ideally, if we performed the same experiment again, we would expect to obtain
identical lists of differentially expressed genes (gene lists). However, the many sources
of variation present in gene-expression measurements are such that each time a
microarray experiment is repeated, a different gene list is almost always generated. A
correct understanding of the variations in gene expression measurements in a microarray
experiment is one of the main challenges in analyzing microarray data.

2.3 Reproducibility
As a basic requirement in microarray experiments, one must assume that although
lists of differentially expressed genes generated by similar experiments are not identical,
they should at least have high reproducibility. However, recent studies have shown how
unreliable microarray experiments can be: lists of differentially expressed genes,
generated by similar experiments, have low overlap between them (Ivanova, Dimos et al.
2002; Ramalho-Santos, Yoon et al. 2002; Tan, Downey et al. 2003).
Parametric models, commonly used to measure differential expression are based
in standard t-statistics, in which gene lists are selected by their p-value ranks. Similarly,
non-parametric models such as Wilcoxon rank-sum tests are also used to generate
measures of differential expression and their corresponding p-values (Shi, Tong et al.
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2005; Shi, Reid et al. 2006). In both parametric and non-parametric statistical models,
gene lists generated by most methods have often resulted in low level of reproducibility.
Extensive comparisons in recent work have shown that gene lists based on simple
measures of differential expression such as fold change are often much more reliable than
using more complex methods (Shi, Perkins et al. 2008). Gene lists produced by fold
change, are equivalent to gene lists using standard t-statistics, under the simplifying
assumption that all genes have the same variance in gene expression. Thus, it comes as a
surprise why this simplification would generate much higher rate of reproducibility than
the more ‘statistically’ sound standard t-statistics (or other sophisticated statistics which
assume different gene expression variances). Many possible reasons such as small
number of microarrays (Ein-Dor, Zuk et al. 2006) and sub-optimal standards in the
manufacturing processes (Tan, Downey et al. 2003), have been suggested without a final
conclusion, as to why this happens.
The complexities involved in measurements of differentially expressed genes
make it very likely that most gene expression models are based on incorrect assumptions,
and thus incorrect p-values are generated. Ranking genes using fold change, which is
equivalent to assuming that the variance in gene expression is constant for every gene
(homogenous variances), is also not a perfect assumption. However, results based on the
high reproducibility of gene list overlaps have suggested that the assumption of
homogeneous variances is valid (Shi, Perkins et al. 2008). In contrast, most methods
which assume a different variance for every gene, model correctly the middle of the true
distribution of the measure of differential expression, but often generate distortions when
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modeling the tails. Since selecting for lists of differentially expressed genes is a decision
problem involving the tails, incorrect modeling of the tails will often produce sub-optimal
gene lists.
In order to overcome the limitations of standard t-statistics we developed a
measure of differential expression based on ranks of gene expression for every
microarray. At the time our method was developed, the study by Shi and Perkins was not
yet published, yet potential benefits of ranking each microarray based on the expression
values had already been demonstrated

(Qin, Kerr et al. 2004) .

Our approach was tested on five yeast datasets using two channel microarrays and
where RNA transcript abundance (gene expression) was measured and normalized using
the software GenePix 6.0. Each dataset consisted of yeast grown in stationary phase,
where Q (quiescent) and NQ (non-quiescent) cell populations were separated from
stationary phase cultures using density centrifugation.
Our goal was to identify differences in gene-expression between Q and NQ and
determine the GO biological processes that differ most between these two cell
populations. Since Q and NQ populations are sub-populations of stationary phase
cultures, and are originated from the same subject, they are likely to be highly correlated
and therefore a paired-design was used, where differences between transformed intensity
values were taken for every Q/NQ pair of microarrays. Although our method was tested
in paired-design datasets it is also applicable to non-paired designs. Summarizing, for all
five datasets, each stationary phase culture gave rise to a pair of microarrays Q and NQ.
For each corresponding pair of microarrays, differences in log-intensity between Q and
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NQ were taken generating a corresponding array of paired differences in log-intensity
(Table 1). Datasets 1, 4 and 5 use biological replicates and therefore are classified as
homogeneous, whereas datasets 2 and 3 have different strains (deletion mutant), and
therefore are classified as heterogeneous.
Table 1 - Description of datasets, number of arrays, number of paired-difference samples
and total microarrays used in this study.
DATASET
1
2
3
4
5

Description
Biological replicates in SP ‐ BY4742
Different mutants in SP
Different mutants in SP
Biological replicates in SP ‐ BY4742
Biological replicates in SP ‐ S288C

# strains # cultures # arrays
1
6
12
80
80
160
88
88
176
1
16
32
1
10
20

Q arrays NQ arrays
6
6
80
80
88
88
16
16
10
10

In dataset 1, auxotrophic parental BY4742 strains were grown and separated into Q
and NQ populations using a two-step density-gradient protocol (Allen, Buttner et al.
2006). As a result, 6 biological replicates (strains) from each Q/NQ population were used
for a total of 12 microarrays. The remaining 4 datasets (Aragon, Rodriguez et al. 2008)
were processed similarly to dataset 1. Due to the paired-design structure of our approach,
we only used cell populations that separated into Q and NQ. Dataset 2 had 80
microarrays from the Q population and 80 from NQ, where each microarray measured the
gene expression profile of a different yeast deletion mutant strain. Dataset 3, similar to
dataset 2, had 176 microarrays from 88 mutant strains. Datasets 4 and 5 had 32 and 20
microarrays respectively, and correspond to 16 auxotrophic parental (BY4742) strains
and 10 wild type (S288C) strains (Table 1).
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2.4 Ranked differential expression and generation of gene lists
To identify the genes strongly associated between Q and NQ, we calculated for
each gene a measure of differential expression between Q and NQ for all microarrays in
the dataset. If the measure of differential expression for a gene is positive, this gene is
more highly expressed in the Q population. Conversely, if the measure of differential
expression is negative, this gene is more highly expressed in the NQ population. Our
goal is to obtain gene lists from both Q and NQ and obtain GO enrichment from the
Saccharomyces Genome Database Gene Ontology (Ontology ; TermFinder) as a measure
of performance of gene lists.
Two versions of the ranking method, the original version (version 1) and an
improved version (version 2) were developed, with both having superior performance
compared to standard t-statistics. Both versions generate p-values based on t-statistics,
with version 1 assuming different variances (after rank transformation) for every gene,
and version 2 assuming the same variance (after rank transformation) for all genes.
Initially we use these two versions to generate overall measures of differential
expression, by combining transformed intensity values in all microarray pairs. Next, for
each version we generated gene lists of different sizes, and for each size we compared
GO enrichment between the corresponding genes lists for each version for Q only (due to
the fact that enrichment results for NQ were very unstable since each gene list from a
different method produces vary different GO enrichment output, making them hard to
compare).

Given the many limitations observed in the two versions, we developed a
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much more powerful approach, Calibration Regression Analysis of Microarrays
(CRAM), which is described in chapter 4.

2.4.1 Generation of gene lists – algorithm version 1
The goal of the rank transformation used by this version is to minimize the effect
of outliers, which is done by normalizing the data using a z-statistic transformation for Q
similarly, a z-statistic transformation for NQ. From this point on, the differences between
the transformed

z-statistics for Q and NQ are taken for every pair of arrays. These

are then combined to generate a ranked based t-statistic. The following is a step-by-step
methodology for the microarray statistical ranking analysis. For this purpose, let the
dataset have 2k microarrays with k corresponding pairs of arrays of Q and NQ and n be
the number of genes in the dataset.

Ranked t-statistics - version 1
For each array,
1.

Replace each missing value with the median of the non-missing values in the

array. This enables us to manipulate the expression values for every gene and at the same
time, minimize the impact of the replacing value (which is close to zero). To minimize
the bias in the data, we could also chose to add to the median, a small random error (such
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as the mean error under a two way ANOVA), although in this particular case (using the
five tested datasets), results were similar with or without the addition of a random error.
2.

Rank each array in ascending order, generating a vector r of size n, where each

element ri contains the rank of gene i within the array. This transforms the data in each
array into ranks, thus minimizing the effect of outliers.
3.

For each gene i, its rank ri is transformed to a value pi between 0 and 1, through
the expression
pi = (ri − 0.5) / n

4.

Use the inverse standard normal cumulative distribution function Φ -1 to

transform pi into a corresponding z-statistic (standard Normal random variable with mean
zero and standard deviation one), which is a robust statistic for every gene.
zi = Φ -1(pi)

For each corresponding pair j of complementary arrays (Q and NQ),
5.

Denote zQj the vector of z statistics corresponding to the quiescent array and

zNQj the vector of z statistics for the corresponding non-quiescent array.
6.

Let dj = zQj − zNQj , be a vector of differences with components dij

corresponding to each gene i from array pair j. This step generates the vector of
differences between the transformed statistics.
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For each gene i,
7.

Calculate the average ui over all elements of dj

ui =

1
k

∑

k
j =1

dij

8.

Denote si, standard deviation of dij across arrays for each gene i.

9.

Let ai which is assumed to be a t-statistic with k − 1 degrees of freedom, be given

by
ai = k ui / si,
which is measure of differential expression for gene i.
10.

Estimate a two tail p-value for gene i using T(ai , k - 1), the cumulative

distribution function of a t-statistic with k - 1 degrees of freedom evaluated at value ai,
given by
p-valuei = 2T(-|ai|, k -1)
At this stage, a p-valuei for each gene for the overall difference between Q and

11.
NQ has

been calculated.
This p-value will be used to determine if a gene is significantly differentially

expressed.
12.

Let C be the level of significance for every gene, specified by the user.

13.

If p-valuei < C, and ai > 0, then the gene i is selected such that classi = “Q”.
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This generates a gene list where genes are differentially more expressed in Q than
in NQ.
If p-valuei < C and ai < 0 then classi = “NQ” . This generates a gene list where
genes are differentially more expressed in NQ than in Q.

Note: if p-value ≥ C, classi is not classified as “Q” or “NQ”, that is classi = blank.
Note: steps 12 and 13 can be replaced if instead of selecting by p-value cutoff, we select
for the m most significant p-values, where m is chosen arbitrarily by the user in a similar
way as C.

2.4.2 Generation of gene lists – algorithm version 2
In version 1, which is based on a rank-transformed t-statistic measure of
differential expression, we have achieved noise levels below those produced by a
standard t-statistics. However, in version 1, genes have different variances in the ranktransformed gene expression values. In order to generate an even more robust measure
of differential expression, we developed version 2, which is based on the assumption that
variances in the transformed expression values are homogenous, and therefore assumes
every gene has a variance equal to the average of the variances over all genes. This is
equivalent to a fold change of the rank-transformed statistics. We expect that at least
under certain conditions (heterogeneous data) version 2 will be more robust than version
1. This superior robustness in heterogeneous data from version 2, comes from the fact
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that even with rank-transformed data, gene variances (estimated by version 1) are highly
distorted when large biological variability is present among samples.

Ranked t-statistics - version 2
Steps 1-7 as in version 1.
For each gene i,
Let ai, which is assumed to be approximately a z-statistic, be given by

8.

ai = ui / k
This is equivalent to an expected fold change across array pairs.
9.

Estimate a two tail p-value for gene i , Φ the cumulative distribution function of

the standard normal distribution is used:
p-valuei = 2 Φ (-|ai|)
10.

At this stage, a p-valuei for each gene for the overall difference between Q and

NQ has

been calculated.
This p-value will be used to determine if a gene is significantly differentially

expressed.
11.

Let C be the level of significance for every gene, specified by the user.

12.

If p-valuei < C, and ai > 0, then the gene i is selected such that classi = “Q”.
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If p-valuei < C and ai < 0 then classi = “NQ” .
Note: if p-value ≥ C, classi is not classified as “Q” or “NQ”.
Note: steps 11 and 12 can be replaced if instead of selecting by p-value cutoff, we select
for the m most significant p-values, where m is chosen arbitrarily by the user in a similar
way as C.

The choice of C, the level of significance for cutoff purposes, depends on how
many false positives one is willing to accept. For example, let us assume our dataset has a
total of 6,000 genes and that by using a cutoff level = 0.01, we get a total of 200 genes
more highly expressed in Q than in NQ. Under the assumption of a random scenario, the
expected number of genes is equal to 60 genes (6000 x 0.01), which is the number of
genes that could have been selected just by chance. Thus, we can say that within the 200
selected genes, we expect to have on average a total of 60 false-positive genes (genes that
do not belong to the set of differentially expressed genes), leaving us with only 140 true
genes. This corresponds to a false discovery rate equal to 30% = (60/200). To illustrate
this example in a more formal way, we define false discovery rate as the probability that
a gene is our list is not differentially expressed and we represent it by P(False | List). So
let:
F represent the event that the gene is not truly differentially expressed,
T represent the event that the gene is truly differentially expressed,
L represent the event that the gene belongs to the gene list.
Using Bayes theorem, we have:
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P(F | L) = P(L | F)P(F)/P(L) = P(L | F)P(F)/( P(L | F)P(F) + P(L | T)P(T) ).
Since we have no prior information about the probability that a gene is be either True of
False, we let P(T) = P(F) = ½ and therefore P(F | L) simplifies to
P(F | L) = P(L | F)/( P(L | F) + P(L | T) ) =
P(L | F) / P(L) = 1%/(200 / 6000) = 1%/(1 / 30) = 30%
Assuming we had prior information that P(T) = 5%, that is, only 5% of the genome is
truly differentially expressed, we would have:
P(F | L) = (1%)(95%)/( (1%)(95%) + (200/6000)(5%)) = 85.1%
The main idea is that since we had prior knowledge that it was much more likely for the
gene not to be differentially expressed, the false discovery rate (FDR) became much
higher. The main limitation when selecting a gene list is to know which genes are the
ones truly differentially expressed and which are not. In the example described, we are
unable to know which are the true 60 genes and the false 140 genes. In this case, prior
knowledge of the probability of a gene being differentially expressed can be highly
informative and will generally lead to a smaller gene list (based on a p-value cutoff),
when the prior probability of a gene being differentially expressed is low. Since it is
common for scientists to work with FDR < 15% (although this can vary depending on the
experiment), and in the example where P(T) = 5%, we had an unacceptable FDR of
85.1%, in order to keep FDR below 15%, we would have to make our p-value cutoff
level under 3.1E-4. A more detailed description of this framework, also referred to as
False Discovery Rates (FDR) is found in (Benjamini 1995).
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We should also be aware that any statement about false positives is based on the
assumption that the p-values from the measure of differential expression are correct. In
almost all methods, including versions 1 and 2, there are distortions on the tails of the
distribution of the measures of differential expression which leads to distortions of pvalue estimates (Fodor, Tickle et al. 2007). Thus, inferences involving false positive
rates must be viewed with caution in all differential expression methods. The most
common consequence of incorrect estimation of p-values in these tails, is the
underestimation of p-values, leading to the generation of gene lists larger than they
should be. However, the accuracy of the p-values generated by version 2, based on the
suggestion by (Fodor, Tickle et al. 2007; Reid and Fodor 2008) is largely improved,
resulting in a better fit for the distribution tails, and thus, generating more accurate gene
lists. This improved modeling of the tail of the distribution of differential expression
measures, is particularly useful when gene lists are generated based on p-value cutoffs.

2.5 Measures of gene list overlaps
A measure of Gene Ontology category enrichment for a gene list can be
generated using the software application GO Term Finder, in order to generate p-values
for GO categories obtained from a gene list. This software is used for measuring
enrichment of a single gene list, which is equivalent to generating a p-value for the
overlap between two sets of genes (the gene list originally generated and the set of genes
belonging to a GO category). GO Term Finder uses a simple statistical method based on
the hypergeometric distribution, which is also used to measure the significance of the
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overlap between two sets of genes (generated as a result of different treatments).
However, valuable biological information can be obtained when three or more sets of
genes are observed with their multiple pair-wise overlaps. For this purpose we have
developed a multi-dimensional approach to generating p-values for gene list overlaps.
An example is described using the three sets of genes, which measures GO category
enrichment using two gene lists (GO category set of genes + two gene lists).

2.5.1

Generation of p-value for Gene Ontology (GO) categories
Before describing the improved methodology to measure GO enrichment of a

gene list, I will describe the standard methodology currently used by GO Term Finder.
The goal of measuring GO enrichment is to infer biological knowledge based on the level
of concentration of annotated genes present in our gene list. For this purpose, a gene list
is submitted to GO Term Finder and a p-value is returned for the most significant
categories from a set of approximately 2000 annotated categories. Next, I present an
example of how the p-value is generated for a specific GO category.
Let T denote the total number of genes (in the population)
Let k be the number of genes of the GO category (the number of successes in the
population)
Let m be number of genes in the submitted gene list (sample size)
Let l be the observed overlap, defined as the number of genes present in the overlap
between the set of m genes from our submitted gene list and the set of k genes from the
GO category. In other words, l is the number of genes present in both the submitted gene
list and the GO category.
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Next, under the hypergeometric distribution assumption, let X be the random variable
representing the unknown number of successes of the sample before the observed
outcome of l successes. The p-value after observing l genes belonging to the specific GO
category is calculated by the following expression:
min{k ,m}

p-value =

∑

P(X = i) ,

i =l

where P(X = i) , is given by the hypergeometric probability density function
P(X = i) =

Cik CmT −−ik
CmT

Calculating the p-value under the hypergeometric distribution assumption is not straight
forward since we need to use the hypergeometric cdf (cumulative distribution function),
which is not present in standard software (such as Microsoft Excel), thus more
mathematically sophisticated software is required. Thus, in order to estimate the p-value
for the hypergeometric distribution, an approximation is used with very similar practical
results. The p-value for the hypergeometric distribution function can be approximated by
a standard normal distribution through the following procedure:
E[X] = µ = mk / T

and

Var[X] = σ2 = µ( T – k)(T – m)/(T(T–1))
A z-statistic is calculated by
z = (l – µ)/ σ,
and a one-tail p-value is calculated by
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p-value = 1– Φ(z)
where Φ is the standard Normal cumulative distribution function. The numerical
example below clarifies the procedure.
Example:
Let T = 6300, the total number of genes of the data set.
Let m = 630, the number of genes in the gene list.
Let k = 200, the number of genes of a specific process, say “protein biosynthesis”.
Let l = 100, the number of observed genes in the category “protein biosynthesis”
belonging to our gene list. Then, p-value =

200

∑

P(X = i). Since the proportion of the

i =100

number of genes m in our gene list with respect to the total number of genes T is m / T =
630/6300 = 10%. Thus, we expect to have by the independence assumption, 10% of the
total number of genes from the “protein biosynthesis’ category (10% of 200 = 20 genes)
that belongs to our gene list.
The ratio lT/(mk) = (100)(6300)/((630)(200)) = 5, describes how much more
concentrated the genes from the category “protein biosynthesis” are present in our gene
list, compared to the expected number of genes from that category in a random gene list
of size m.

Both measures (p-value and the ratio) should be used together as a way to

obtain the enrichment of a gene list. This approach may be extended by analyzing
enrichment between overlaps of any pair of gene lists.
A one-tail p-value is used (instead of two-tail) in all calculations of GO
enrichment, since researchers are interested in genes from a gene list that are more highly
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concentrated (greater than the expected overlap under a random scenario) in a GO
category, and are rarely interested in genes from a gene list that are underrepresented in a
GO category. Moreover, if a researcher is interested in genes that are underrepresented in
a particular GO category, it is unlikely that there will be enough statistical power to have
a level of significance < 0.01. As an example, let m equal the expected number of
overlapping genes between our gene list and genes from a specific GO category. We
assume two scenarios: we observe a total of m+a overlapping genes in the first scenario,
and a total of m-a overlapping genes in the second scenario. The p-value in the first
scenario is much more likely to be significant than in the second scenario. This is due to
the fact that the probability of a gene from our gene list to belong to a GO category in
most cases will be much smaller than the probability of the same gene not belonging to
the GO category. Thus, the likelihood of observing an overlap with m+a genes, will be
greater than the likelihood of observing m-a genes. Moreover, we can easily adapt the pvalue generating algorithm to perform two-tail p-values.

2.5.2

Measuring GO enrichment – two gene lists
Here, we describe a novel method of measuring GO enrichment using two lists

and compare it with the standard method using the ‘unknown’ GO category as an
example. The reason for choosing the ‘unknown’ GO category is because it is suited to
detect novel genes not yet assigned to any particular known GO biological process (Fig. 1
and 2). Although we have chosen to illustrate our examples with the ‘unknown’ GO
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category, this enrichment approach using two gene lists can be applied in a single step to
all the thousands of GO categories.

Gene list

unknown

High
overlap

Figure 1- Example of a high overlap between the ‘unknown’ GO category and a single
gene list. A high overlap, which is an overlap significantly greater than expected overlap
between two sets by the independence assumption (or by chance) is indicative of
potential candidate genes for belonging to either a new GO category or an existing one.
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Gene list B

Gene list A
High
overlap

unknown
Figure 2 - Example of a high overlap among the ‘unknown’ GO category and two gene
lists. A high triple overlap, which is an overlap significantly greater than the expected
overlap among 3 sets by the independence assumption (or by chance), is indicative of
potential candidate genes for belonging to either a new GO category or an existing one.

To illustrate the method, I will use the gene lists generated from datasets 2 and 3
obtained from (Aragon, Rodriguez et al. 2008). Datasets 2 and 3 generated respective
gene lists A and B, of respective sizes 1080 and 1374 for genes classified as ‘Q’ with a
total of 683 genes present in the overlap between both gene lists (Fig. 3).
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List A

397

List B

683

691

Figure 3 – Venn Diagram for gene lists high in Q relative to NQ, obtained from datasets
2 and 3. The overlap of 683 genes, measures the number of genes present in both lists.

There are 2540 genes in the “unknown” GO category annotated in the GO database, of
which 232 genes are also present in the overlap of 683 genes between lists A and B. So if
we name list U as the list of all 2540 genes in the ‘unknown’ GO category, the set of 232
genes will have a set theory representation as (A∩B)∩U. Assuming both datasets have a
total of 6359 genes each, under the random assumption, then we have 2504 x (683/6359)
= 269 expected number of genes (within the ‘unknown’ GO category) in the overlap.
Generating the ratio between the observed 232 genes and the expected 269 genes, we
have a ratio of 232/269 = 0.86 < 1, which is less than the expected, under a random
sampling, resulting in a non significant p-value.
Let us assume that the population is the set of all genes from the ‘unknown’ GO
category, corresponding to the lower portion of the Venn diagram (Fig. 4), resulting in a
total of 591 genes, representing the overlap between: the overlap of the ‘unknown’
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category (2504 genes) and set A (385 genes), with the overlap between the ‘unknown’
category (2504 genes) and set B (438 genes), which is represented by (A∩U) ∩(B∩U).

Figure 4 - Venn diagram for gene lists high in Q relative to NQ, obtained from datasets 2
and 3. The overlap of 232 represents the number of genes from the ‘unknown’ GO
category present in sub list UA and also in sub list UB.
Thus, sub list UA (385 genes which can be represented by A∩U), containing only genes
from the ‘unknown’ GO category, and similarly sub list UB (438 genes which can be
represented by B∩U). The overlap between both lists is equal to 232 genes from the
“unknown” category. However, the expected number of genes in the “unknown”
category in the overlap between lists A and B is equal to 385 x (438 / 2504) = 67.3. This
generated a p-value that was very significant (2.8E-100) and a ratio equal to 232/67.3 =
3.45. The main interpretation of this result is that a highly significant number of the
same genes from the “unknown” category are present in both lists A and B, even though
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the total number of genes (232) in the “unknown” category in the overlap between A and
B is less than the expected overlap (269). The representation in set theory of our list of
232 genes in this scenario is given by (A∩U) ∩ (B∩U). So it is interesting to notice that
although the list of 232 genes can be represented by either (A∩B) ∩ U or by (A∩U) ∩
(B∩U), which are identical, both methods give totally different p-values, as a result of
different expected overlaps (269 vs. 67.3), and therefore depend on the order which they
are applied using the hypergeometric distribution function. This is a characteristic of
triple overlaps as well as higher dimensional overlaps which will be explained in more
detail in section 2.5.3.
Consider the following example using a normal approximation for the
hypergeometric distribution, is presented in which we estimate the p-value for the overlap
between sub list UA and the sub list UB.
µ = mk / T = 385x438/2504 = 67.3
σ2 = 67.3(2504 – 385)(2504 – 438)/(2504(2504-1)) = 47.00 , then σ = 6.85
A z-statistic is calculated from z = (l - µ)/ σ = (232 – 67.3) / 6.85 = 24.02
The p-value using the normal approximation to the hypergeometric distribution, which is
given by the expression 1 - Φ(24.02) = 8.5E-128, when compared to the p-value (2.8E100) using the true hypergeometric distribution, gives slightly different values, although
for practical applications the conclusion is nearly the same, that is, the observed overlap
of 232 genes is very significant, making these ‘unknown’ genes, good candidates for
being classified into either a new GO category or an existing GO category. In addition,
the high significance of the observed overlap, indicate that these genes are likely to be
correlated and therefore are good candidates to belong to the same pathway.
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We should keep in mind that when using (A∩B) ∩ U to measure the significance
of the triple intersection, we are asking the question: how significant is the number of
‘unknown’ genes present in both datasets A and B? On the other hand, when using
(A∩U) ∩ (B∩U), the question is: how significant is the overlap between the ‘unknown’
genes from datasets A, and the ‘unknown’ genes from dataset B? As we can see, these
are two different questions, each generating a different expected value for the triple
overlap, and therefore, different levels of significance are obtained for the observed
overlap of 232 genes.

2.5.3

Analyzing pair-wise and triple overlaps - Examples
In the previous section, we illustrated an example of how the significance of the

triple overlap (A∩B∩U) gave two different results, depending on the order in which the
triple overlap was generated. This is a typical characteristic of triple overlaps. The
overlap between three sets which is a natural extension of the commonly used overlaps
between two sets, has many applications in biological problems. To better explain
applications involving triple overlaps, two practical examples are illustrated using Venn
diagrams from data from experiments in (Aragon, Quinones et al. 2006). One of the
main goals in these experiments was to determine if stress resistance in stationary cells
would protect against oxidative stress (induced by the use of menadione).
In our first example, three treatments were used in stationary phase cultures where
each treatment generated a list of differentially expressed genes, corresponding to genes
that had ≥ 2 fold increase in transcript abundance relative to its initial condition (before
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the treatment). Three treatments were applied, Proteinase K, 1 minute oxidative stress
and 30 minutes exposure to high-temperature, in which three gene lists were generated.
A Venn diagram with the overlap between three gene lists under the following three
different treatments produced the following results (Fig. 5).

Figure 5 - Venn diagram of transcripts that increased after three treatments were used:
oxidative stress, proteinase K or high temperature. Transcripts were evaluated if they had
a ≥2 fold increase relative to T0 cell lysates: abundance by 1 minute oxidative stress or 30
minutes after oxidative stress or after proteinase K treatment. Transcripts were also
required to have good spots in 80% of the time points.

A significant overlap was detected between the gene list generated using Proteinase K
and the gene list generated by 1 minute oxidative stress. Another significant overlap was
detected between the genes list generated using Proteinase K and the gene list generated
by a 30 minute exposure to increased temperature. There was a significant triple overlap
(Table 2).
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Table 2 - P-values and ratios for all pair-wise overlaps and the triple overlap between
gene lists obtained from the treatments Proteinase K, oxidative stress or high temperature.
Ratios are defined as the observed overlap divided by expected overlap. Total genes =
6359.
Overlap
p-value
Overlap
expected
Ratio
1.5E-164
606
263.18
2.30
(PK vs. OS)
1.1E-15
148
87.11
1.70
(PK vs. HT)
3.1E-01
45
39.29
1.15
(OS vs. HT)
6.1E-09
37
18.3
2.02
(OS vs. HT) vs. PK

In another experiment from the same article, a comparison between three other
treatments was tested. The three treatments were Proteinase K, 1 minute oxidative stress
and 30 minutes of oxidative stress. Similar to our previous examples, the three
treatments were used in stationary phase cultures where each treatment generated a list of
differentially expressed genes, corresponding to genes that had ≥ 2 fold increase in
abundance relative to its initial condition.

A Venn diagram showing the overlaps

between all three treatments is presented (Fig. 6).
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127

1 minute
oxidative
stress

125

253
381
225

329

30 minute
oxidative
stress

1650

Proteinase K
Figure 6 - Venn diagram of transcripts that increased by ≥2 fold increase in: abundance
by 1 minute oxidative stress or 30 minutes after oxidative stress or after proteinase K
treatment. Transcripts were also required to have good spots in 80% of the time points.
In this case, all pair-wise overlaps were very significant. The triple overlap was also
significant although this was expected given the significance of all three pair-wise
overlaps (Table 3).
Table 3 - P-values and ratios for all pair-wise overlaps and the triple overlap between
gene lists obtained from the treatments Proteinase K, 1 minute oxidative stress or 30
minutes of oxidative stress for T0 cell lysates. Ratios are defined as the observed overlap
divided by expected overlap. Total genes = 6359.
Overlap
p-value
overlap
expected
Ratio
(PK vs. 1min OS)
2.4E-59
608
388
1.56
(PK vs. 30 min OS)
(1min OS vs. 30 min OS)
(PK vs. 30 min OS) vs. 1 min
OS

5.4E-49
2.9E-231

710
508

493
164

1.44
3.10

1.6E-242

381

95.8

3.98
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2.5.4

Multi-dimensional overlaps
We have seen some examples of how overlap analysis of gene lists is not limited

to two dimensions and can potentially be extended to multiple dimensions. Since
biological systems are such that multiple interactions can occur, overlap analysis can be
used to effectively detect some of the higher order interactions. We will illustrate some
potential applications of multi-dimensional overlap analysis in detecting higher order
interactions.

2.5.4.1 Measuring the significance of a triple overlap
There are many ways of measuring the significance of a triple overlap between
given gene lists A, B and C. We can measure the triple overlap by six different ways:
1. (A∩B) ∩ C
2. (A∩C) ∩ B
3. (B∩C) ∩ A
4. (B∩A) ∩ (C∩A)
5. (C∩B) ∩ (A∩B)
6. (A∩C) ∩ (B∩C)
In the first case, we can evaluate the overlap (A∩B) first and obtain the p-value
of the overlap (A∩B) with C. In the second case we can evaluate the overlap (A∩C)
first and then obtain the p-value for the overlap (A∩C) with B, and finally, in the
third case we can obtain the overlap between (B∩C) first and obtain the p-value of
the overlap between (B∩C) with A. Similarly, in cases 4, 5 and 6, we take the
overlap between pair-wise overlaps. The interesting fact is that all six cases will give
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different p-values when measuring the significance of the triple overlap (A∩B∩C).
This happens due to the fact that the expectation for the triple overlap is different in
each one of the six cases. In order to define the significance of a triple overlap, we
recommend choosing the most significant overlap between the six cases (the case
where the expectation is the smallest). We will show in subsection 2.5.4.3, how to
optimize the selection of the most significant triple overlap.

2.5.4.2 The non-greedy triple overlap
Let’s assume gene lists A, B and C, are such that all pair-wise overlaps (A∩B),
(A∩C) and (B∩C) have insignificant overlap but (A∩B∩C) has a significant overlap.
Although a multidimensional hypergeometric method is capable of detecting this type of
overlap, they are quite limited since they do not use any knowledge of pair-wise overlaps.
This limitation becomes clear in the example used in figure 4 with the ‘unknown’ GO
category. In this example, by assuming independence between sets A, B and U, we have
an expected triple overlap equal to 6359 x (1080/6359) x (1374/6359) x (2504/6236) = 92
which is still greater than the expected overlap (A∩U) ∩ (B∩U) which is equal to 67.
Moreover, we should also keep in mind that if we want to detect the significance of all
overlaps in higher dimensions, we might run into a computationally unfeasible problem.
A more realistic approach, applied to three or more dimensions may be found in the
example using the greedy triple overlap described next.
2.5.4.3 Greedy overlap analysis
In the greedy overlap approach to evaluating the significance of triple overlaps, we
assume that in order for a triple overlap to be significant, there has to be at least one
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significant pair-wise overlap. To give a better idea, let us assume gene lists A, B, C are
such that overlap (A∩B) is a significant overlap, but overlaps (A∩C) and (B∩C) are not
significant, indicating that C does not interact with either A or B. However, if the triple
overlap (A∩B) ∩ C is significant, this implies that C interacts with the set (A∩B). When
the number of genes in each set A, B and C is large (>50), we can use a binomial
approximation to estimate the expected values of overlaps. We present how the
expectation in calculated for each of the six cases previously described (Table 4).
Table 4 – Approximate expectation using the binomial approximation for all six
cases of triple overlaps. In the first column, we have each triple overlap. In the second
column we have the corresponding formula for calculating the expected overlap (#A, #B,
#C represent the total number of genes from each set; #T represents the total number of
genes used in the experiment; #(A∩B), #(A∩C), #(B∩C) correspond to the number of
genes in the pair-wise overlaps). The third column represents the expected overlap with
the data from figure 5.
Triple Overlaps

1.
2.
3.
4.
5.
6.

(A∩B) ∩ C
(A∩C) ∩ B
(B∩C) ∩ A
(B∩A) ∩ (C∩A)
(C∩B) ∩ (A∩B)
(A∩C) ∩ (B∩C)

Expected triple overlaps
#(A∩B)(#C/#T)
#(A∩C)(#B/#T)
#(B∩C)(#A/#T)
#(B∩A)#(C∩A)/#A
#(C∩B)#(A∩B)/#B
#(A∩C)#(B∩C)/#C

expectation
18.3
27.1
20.0
31.8
23.5
34.7

Since the smallest expected overlap is 18.3 (from case 1), we select this as the optimal
way to measure the significance of the triple overlap, and has a p-value equal to 6.1E-09.
Had we chosen the largest overlap (from case 6), with expected overlap equal to 34.7, the
corresponding p-value would have been equal to 0.32, which is not significant. An
interesting fact in this example, is that the p-values for the pair-wise overlaps (A∩B),
(A∩C) and (B∩C) are respectively equal to 0.59, 1.3E-82, 1.6E-22, and at the same time,
the overlap (A∩B) ∩ C is the most significant triple overlap. We can say that since the
pair-wise overlap (A∩B) is the least significant, it also has a low expected overlap,
48

making it a good candidate to also generate a low expected triple overlap. Thus, in a
greedy approach, our best candidates to measure the significance of the triple overlap in
the example in table 4, would be (A∩B) ∩ C and (A∩B) ∩ (B∩C), which correspond to
cases 1 and 5, (A∩B) ∩ C is equivalent to the least significant pair-wise overlap (A∩B)
overlapped with the remaining set A, and where (A∩B) ∩ (B∩C) is equivalent to the
least significant pair-wise overlap (A∩B) overlapped with the second least significant
pair-wise overlap (B∩C).
Applying the step-wise procedure to the results obtained in figure 4, where the
‘unknown’ GO category was used, if we take all three pair-wise overlaps (A∩B), (A∩U)
and (B∩U), their corresponding p-values are respectively 9.9E-292, 4.9E-3 and 0.35.
The least significant of these pair-wise overlaps is (B∩U), and therefore, this leaves us
with two candidate overlaps: (B∩U) ∩ A or (B∩U) ∩ (A∩U). The corresponding
expected overlaps for both (B∩U) ∩ A and (B∩U) ∩ (A∩U) are equal to 74.4 and 67.3,
and therefore since

(B∩U) ∩ (A∩U) has the smallest expected triple overlap, it

is the most significant triple overlap.
The procedure of testing all combinations of three overlaps can be easily extended
to testing all combinations of higher order overlaps. However, we should remember that
the number of overlaps (cases as presented in table 4) increases exponentially as a
function of the number of dimensions. Remembering that the step-wise procedure
greatly reduces the number of overlaps in which the significance is measured, we can
extend the procedure to higher order overlaps but at the same time we can be
computationally efficient. This is the goal of the greedy approach.
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We can extend this procedure to higher order overlaps using the greedy approach,
if we consider only overlaps such as cases 1 to 3 in table 4 (we do not include the more
complex overlaps such as cases 4 to 6).

To illustrate the algorithm, we will use as an

example a 5 dimensional overlap, using sets (gene lists) A, B, C, D and E.
Let #T be the total number of genes in the experiment, and #A,#B,#C,#D and #E,
be the total number of genes for corresponding sets A,B,C,D and E. We first need to
know if the multiple overlap A∩B∩C∩D∩E is underrepresented or overrepresented. We
define as overrepresented if the number of genes in the multiple overlap
#(A∩B∩C∩D∩E) > #A(#B/#T)(#C/#T)(#D/#T)(#E/#T),
which is the expected overlap assuming all 5 sets are independent. Similarly we say
A∩B∩C∩D∩E is underrepresented if
#(A∩B∩C∩D∩E ) < #A(#B/#T)(#C/#T)(#D/#T)(#E/#T) .
Let us assume A∩B∩C∩D∩E is overrepresented. Then in order to maximize the
significance of the multiple overlap, we should minimize the expected multiple overlap,
which in this case is the expected fifth-order overlap. To minimize the expected fifthorder overlap, we chose the lower-order overlaps such that the expected overlap is the
smallest as possible. Let the lift between two sets S1 and S2 be defined as:
Lift(S1,S2) = #(S1∩S2)/(#S1(#S2/#T))
For example, if #(A∩B) < #A(#B/#T), meaning that the pair-wise overlap A∩B is
underrepresented, then we have Lift(A, B) = #(A∩B)/(#A(#B/T)) < 1. Thus Lift
between two sets can also be viewed as a measure of relative expectation. In this
example with 5 sets,
#(A∩B)(#C/#T)(#D/#T)(#E/#T) < #A(#B/#T)(#C/#T)(#D/#T)(#E/#T),
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which results in the fifth-order overlap (A∩B)∩C∩D∩E being more significant than the
fifth-order overlap A∩B∩C∩D∩E. Thus our goal is to find underrepresented (lift < 1)
lower-order overlaps within A∩B∩C∩D∩E, such that the fifth-order expected overlap is
the smallest. In this example, (where the fifth-order overlap is overrepresented), we start
by selecting from all pair-wise overlaps, the one with the smallest lift.
Say the pair-wise overlap (A∩B) is such that its lift #((A∩B)/(#A(#B/#T)) is the
smallest among all pair-wise lifts. For each remaining set, in our case sets C, D and E,
we select the triple overlaps with the smallest lift among the lifts:
1- #((A∩B)∩C) / #(A∩B)(#C/#T)
2- #((A∩B)∩D) / #(A∩B)(#D/#T)
3 - #((A∩B)∩E) / #(A∩B)(#E/#T)
4- #((A∩B)/(#A(#B/#T))
We notice that if the lift in case 4 is selected, it is because that lift is smaller than the lift
in cases 1, 2 and 3. This case is necessary since we want any additional grouping of sets
to improve (decrease) the lift, thus, if no additional grouping improves the lift, we would
chose the lift from the previous step, which is the smallest lift up to this point.
Let case 2, be the overlap with the smallest lift. The fact that (A∩B)∩D is
chosen, indicates that the triple overlap (A∩B)∩D is underrepresented, since
#((A∩B)∩D) is less than #(A∩B)(#D/#T) which assumes that the sets (A∩B) and D are
independent. Next we select the fourth-order overlap with the smallest lift between
1 - #(((A∩B)∩D)∩C) / ( #((A∩B)∩D)(#C/#T) )
2- #(((A∩B)∩D)∩E) / ( #((A∩B)∩D)(#E/#T) )
3- #((A∩B)∩D) / ( #(A∩B)(#D/#T) )
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Once again, case 3 assumes cases 1 and 2 had greater lift than in the previous step. Say
the smallest lift was case 2. Finally we chose the last set C to generate the fifth-order
overlap, so we chose between
1- #(A∩B∩C∩D∩E)/ (#((A∩B)∩D∩E))(#C/#T) )
2- #(((A∩B)∩D)∩E) / (#((A∩B)∩D)(#E/#T) )
Let us suppose case 2 (which was the lift from the previous step) was the smallest
lift. Thus, we assume #(A∩B∩C∩D∩E)/ ( #((A∩B)∩D∩E)(#C/#T) ) is the smallest lift
for the fifth-order overlap. The main interpretation of this fifth-order overlap is that the
fourth-order overlap (A∩B∩D∩E) is underrepresented, such that
#(A∩B∩D∩E) < #(A∩B∩D)(#E/#T) < #(A∩B)(#D/#T)(#E/#T) <
#A(#B/#T)(#D/#T)(#E/#T) and therefore #(A∩B∩D∩E)(#C/#T) is the expected fifthorder overlap and also a good candidate for being the smallest expected overlap (we can’t
be sure it is the smallest since not all possible lower order combinations were considered,
but the greedy solution is likely to be to be close to the optimal).
If the observed overlap A∩B∩C∩D∩E was underrepresented, we would select
at each step for the set that maximized the lift, such that the fifth-order overlap had the
largest expected overlap, and therefore our observed fifth-order overlap would be the
furthest from the expected fifth-order overlap, resulting in the most significant fifth-order
overlap.

2.5.4.4 Variable gene list size overlaps
A more complex and potentially more powerful extension of overlap analysis results
from applying a flexible cutoff for the selection of individual gene lists. As an example,
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consider selecting cutoffs c1, c2 and c3 used to create lists A, B and C, such that the
significance of overlaps is optimized. In this case, c1, c2 and c3 are optimally chosen
such that the expected triple overlap is smallest and therefore the significance of the triple
overlap is highest. However, due to the multiple choices involving c1, c2 and c3, it
would be required to adjust for optimistic p-values which occur as a result of testing for
multiple cutoffs.

2.6 GO enrichment evaluation of gene lists – five datasets
Enrichment for gene lists based on versions 1 and 2 were generated from datasets
described in section 2.2. Both versions were compared by selecting the most significant
GO category of version 1 and then observing its performance when applied to version 2
(Tables 5 to 9). This will lead us to expect that in a random setting, version 1 will most
often have a superior enrichment in relation to version 2. In (Table 5), derived from a set
of biological replicates, version 2 was significantly superior to version 1 for small gene
lists (50 and 100), suggesting that the variance is likely to be distorted leading to inflated
t-statistics. Corresponding GO enrichment (not on table) for list sizes 50 to 400 for the
standard t-statistics showed no GO enrichment.
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Table 5 - Gene Ontology enrichment for most significant category in genes significantly
higher in Q than in NQ. Two tail p-values for the overlap between the two versions are
obtained using the normal approximation of the Hypergeometric distribution. Dataset is
homogeneous.
List size
50
100
200
300
400

Transposition
Transposition
Transposition
Transposition
Transposition

Dataset 1 - Quiescent list
Go category
version 1 version 2 # in cat p-value
RNA-mediated
34
43
93 4.6E-13
RNA-mediated
44
69
93 2.1E-45
RNA-mediated
70
73
93 1.1E-01
RNA-mediated
71
77
93 2.3E-02
RNA-mediated
75
79
93 1.2E-01

In (Table 6), version 1 appears marginally better than version 2. Taking into
consideration that the GO category was selected based on the lowest p-value from
version 1 we can say that both versions have similar enrichment. Corresponding GO
enrichment (not on table) for list sizes 50 to 400 for the standard t-statistics showed no
GO enrichment.

Table 6 - Gene Ontology enrichment for most significant category in genes significantly
higher in Q than in NQ. P-values are obtained using the normal approximation of the
Hypergeometric distribution. Dataset is heterogeneous.
List size
50
100
200
300
400

Dataset 2 - Quiescent list
Go category
version 1 version 2 # in cat p-value
not enriched
Response to oxidative stress
7
6
70 2.5E-01
Response to oxidative stress
12
8
70 2.6E-02
Response to oxidative stress
15
8
70 2.5E-03
Response to oxidative stress
16
13
70 1.5E-01

The results in (Table 7) show that version 2 is significantly superior to version 1 for gene
list sizes of 200, 300 and 400. Taking into consideration that the GO category in version
1 was selected based on the lowest p-value, we can say that version 2 is superior to
version 1 on this dataset. Corresponding GO enrichment (not on table) for list sizes 50
to 400 for the standard t-statistics showed no GO enrichment.
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Table 7 - Gene Ontology Gene Ontology enrichment for most significant category in
genes significantly higher in Q than in NQ. P-values are obtained using the normal
approximation of the Hypergeometric distribution. Dataset is heterogeneous.
List size
50
100
200
300
400

Dataset 3 - Quiescent list
Go category
match v1 match v2 # in cat p-value
Alcohol metabolic processes
10
10
160 5.0E-01
Cell biosynthetic process
27
35 1619 9.5E-02
Cell biosynthetic process
46
74 1619 5.5E-04
Cell biosynthetic process
71
105 1619 5.5E-04
Cell biosynthetic process
95
125 1619 6.0E-03

The results in (Table 8) indicate version 1 is superior to version 2, and although GO
categories in version 1 were selected based on the most significant GO category, the pvalue for the difference between the two versions is very significant, pointing to a clear
superior GO enrichment performance for version 1. Corresponding number of genes for
each GO category (not on table) for list sizes 100 to 400 for the standard t-statistics were
12, 15, 21 and 24 genes. No GO enrichment was found for the t-statistics for list size 50.
Table 8 - Gene Ontology enrichment for most significant category in genes significantly
higher in Q than in NQ. P-values are obtained using the normal approximation of the
Hypergeometric distribution. Dataset is homogeneous.
List size
50
100
200
300
400

Dataset 4 - Quiescent list
Go category
version 1 version 2 # in cat
Generation of precursor metabolites
9
5
181
Monocarboxylic acid metabolic process
8
4
128
Monocarboxylic acid metabolic process
16
11
128
Monocarboxylic acid metabolic process
21
13
128
Monocarboxylic acid metabolic process
23
19
128

p-value
7.9E-03
2.1E-02
3.5E-02
8.6E-03
1.5E-01

The results in (Table 9) indicate that version 1 is marginally superior to version 2.
Taking into consideration that the GO category in version 1 was selected based on the
most significant GO category, we can say that version 1 and 2 are roughly equivalent.
Corresponding number of genes for each GO category (not on table) for list sizes 50 to
300 for the standard t-statistics were 9, 67, 118, 149 genes. No enrichment was found for
the t-statistic for list size equal to 400.
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Table 9 - Gene Ontology enrichment for most significant category in genes significantly
higher in Q than in NQ. P-values are obtained using the normal approximation of the
Hypergeometric distribution. Dataset is homogeneous.
List size
50
100
200
300
400

Dataset 5 - Quiescent list
Go category
version 1 version 2 # in cat p-value
Glycolysis
9
2
22 2.6E-33
Cell biosynthetic process
57
46
1619 3.6E-02
Cell biosynthetic process
117
75
1619 4.8E-07
Cell biosynthetic process
143
98
1619 7.8E-06
Cell biosynthetic process
163
114
1619 2.0E-05

2.7 CONCLUSION – Novel Biological Results
I have presented in this chapter the benefits of measuring the significance of
multi-dimensional overlaps. A useful application was described in which the significance
of a triple overlap was used to determine the enrichment of a GO category and any two
gene lists. Another application measuring significance of triple overlaps involving
experiments with 3 different treatments was also presented.
On the topic of Gene Ontology enrichment of gene lists, we have shown the
benefits of different approaches based on the hypergeometric distribution applied to Venn
diagrams.

The main novelty derives from the combination of GO enrichment measures

using two gene lists. This approach was described as a variation of the triple overlap, in
which we showed that very different p-values could result from the same triple overlap,
depending on the order of pair-wise grouping. Next we presented a general framework of
how to detect multi-dimensional interactions by using multiple gene lists and described
some interpretations of the results. Moreover, a greedy approach was described that can
identify multi-dimensional biological interactions in a computationally efficient way.
On the topic of differential expression, different studies have shown conflicting
results as to selecting gene lists assuming identical gene variances or selecting gene lists
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based on standard t-statistics assuming different variances for every gene. The results
presented suggest that the ideal choice between equal or different gene variances is likely
to depend on the dataset.

To address some of these limitations, we describe in chapter 4

the CRAM algorithm which is far more sophisticated, and of which the latest version,
CRAM-GS, incorporates correlations between genes into the model.
In homogeneous datasets, versions 1 and 2 were roughly equivalent, whereas in
heterogeneous datasets, version 2 was marginally superior. The main reason version 2
was superior in heterogeneous datasets is primarily due to its assumption of same
variance for rank-transformed intensity values, which provides greater robustness than
version 1, making it better to model the more noisy data, present in heterogeneous
datasets. We should also keep in mind that although versions 1 and 2 had similar GO
enrichment performance, version 2 is better to infer measures of false positive rates, since
it produces more accurate p-values.
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Chapter 3 - SDI
A statistical approach for detection of heterogeneous cell
populations in high-throughput flow cytometry data

Osorio Meirelles1, Sushmita Roy2, Ray Joe1, Phillip Tapia1, Chris Allen3, Mark B. Carter3, Susan M.
Young3, Bruce S. Edwards3, Larry A. Sklar3, Margaret Werner-Washburne1
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Center
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3.0 ABSTRACT

Background. Heterogeneous cell populations have previously been described as noisy. However,
recent studies have demonstrated that heterogeneity can be biologically significant. We present
here an approach for rapid and complete identification of heterogeneous cell populations from
high-throughput flow cytometry data. We have developed a novel measure Slope Differentiation
Identification (SDI) using flow cytometry-based protein expression, quantifying the rate of
change in protein expression between two conditions (exponential and stationary phase) of yeast
cells, as a function of cell size or cell granularity. Results. SDI had superior Gene Ontology
enrichment when compared with other approaches such as k-means clustering and an approach
based on the bi-modality of the fluorescence intensity distribution. Cell populations were also
validated using gradient-separation followed by microscopy, where proteins with high SDI
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measure showed significant levels of differentiation between high and low density cells.
Conclusion.

Overall, our approach has identified novel protein expression patterns that

differentiate quiescent and non-quiescent cell populations.

3.1 INTRODUCTION

Heterogeneous cell populations while sometimes thought of as “noisy” can
sometimes result from important differences in cellular function. For example, stationary
phase cultures of the yeast Saccharomyces cerevisiae are known to be heterogeneous
because of the formation of two populations of cells separable by density (Allen, Buttner
et al. 2006; Aragon, Rodriguez et al. 2008). Other differences, such as age, cell cycle
stage, cellular differentiation, and other non-random intra- and inter-cellular differences
can contribute to heterogeneity (Raser and O'Shea 2004; Raser and O'Shea 2005).
Flow cytometry is a technology used to detect fluorescent measurements of cells
passing through a laser beam, where many thousands of cells can be measured, counted
and selected (HTC). The recent application of high-throughput flow cytometry using the
yeast GFP-fusion library (Ghaemmaghami, Huh et al. 2003; Howson, Huh et al. 2005)
(4159 strains, each with a green-fluorescent tagged protein), has led to new challenges in
analysis of proteomics data. High throughput flow cytometry not only measures
thousands of cells in each sample, but potentially hundreds of samples per minute,
producing millions of data points per assay. Analysis of these massive flow datasets
requires sophisticated computational methods for quantifying protein expression and
detecting important population characteristics such as heterogeneity.
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We developed a novel approach called Slope Differentiation Identification (SDI) to
detect heterogeneous cell populations from high throughput flow cytometry data. Our
approach detects heterogeneity by modeling change in fluorescence intensity from two
conditions as a function of cell size or granularity.
We applied SDI to detect heterogeneous cell populations in a flow cytometry dataset
measuring expression levels of ~4000 yeast GFP-fusion strains in stationary phase.
Because stationary phase samples are known to be heterogeneous this dataset served as a
good candidate for validation of SDI as well as discovery of novel strains exhibiting
heterogeneity.
We compared SDI against other approaches for detecting heterogeneity, including
visual inspection and three-dimensional k-means clustering. For each approach we tested
if predicted heterogeneous strains were statistically overrepresented in biological process
categories (GeneOntology). SDI outperformed these approaches, generating
heterogeneous candidate strains that were more overrepresented in biological process
categories, than other approaches. Additional validation with stationary phase cultures,
showed SDI-identified GFP-fusion strains to be strongly associated with heterogeneous
populations identified using gradient-separation and microscopy.
Overall SDI is a computationally efficient approach for analyzing flow cytometry
measurements of thousands of proteins, and detecting strains that are statistically
overrepresented in several biological processes. SDI-identified strains are also highly
likely to form heterogeneous cell populations identifiable by microscopy.
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3.2 METHODS
3.2.1 Generating the data
Slope Differentiation Identification (SDI) was applied on two high-throughput
flow datasets measuring fluorescence intensity of GFP-fusion strains from stationary and
exponential phase cultures. Each dataset contained three technical replicates for each of
the 3941 GFP-fusion strains. A HyperCyt® autosampler (Edwards, Oprea et al. 2004;
Young, Bologa et al. 2005) controlled by HyperSip software was used to measure
fluorescence intensity of approximately 30,000 cells (events) per sample at a sampling
rate of approximately 40 samples/min. The software package IDLQuery (IDLQuery) was
used to capture and analyze data, generating output flow measurements for every strain.
Each sample had approximately 30,000 three-dimensional measurements of fluorescence
intensity, forward-scatter (cell size) and side-scatter (cell granularity). Overall,
approximately 24,000 samples were analyzed in both datasets.

3.2.2 Visual identification of two-peak samples
The software package IDLQuery was used to generate fluorescence intensity
histograms for each GFP sample. Each sample was visually classified as either two-peak,
if it had bi-modal distribution of fluorescence intensity, or as one-peak, if the distribution
of fluorescence intensity was uni-modal.
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3.2.3 Slope Differentiation Identification (SDI) method for unsupervised two-peak
detection
SDI can be generated using either one of the two flow-cytometric measurements:
side-scatter and forward-scatter. We will describe only the SDI measure using sidescatter since the procedure for forward-scatter is identical. To generate SDI measure, we
grouped side scatter measurements from the SP dataset into 100 bins. Side-scatter
measurements from exponential phase were grouped into similar 100 bins. Although we
chose to group by 100 bins, several different numbers of bins were tested with very
similar results for number of bins between 10 and 200. Next, for every sample, profiles
of average log intensity and average side scatter were generated, separately for stationary
and exponential phase datasets using all events within each bin.
The SP samples were combined with their corresponding exponential samples,
forming three sample-pairs* (one pair for each technical replicate). To obtain SDI for
stationary phase, we first calculated the fold change in log fluorescence intensity by
subtracting average log intensity in exponential phase from average log intensity in
stationary phase. This was done for each sample for all bins, generating a profile of fold
change as a function of side scatter, in stationary phase. After excluding GFP strain
which had bad samples in either SP or exponential phase, the initial GFP library of 4159
strains was reduced to 3941 strains.

*The term “sample” and “sample-pairs” both refer to a strain carrying a specific GFP-fusion protein. A sample can be cells from a
stationary or an exponential culture, whereas a sample-pair refers to information from both stationary and exponential phase for a
strain carrying the same GFP-fusion protein.
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We have regressed fold change in log intensity on the average log side scatter using
only bins with ≥50 events in both stationary and exponential datasets, in order to assure
statistical significance of fold change for each bin (we also tested other cutoff values
from 100 to 500 in steps of 50, with similar results). Selecting bins with ≥50 events
assured statistical confidence in estimations of average log-intensity and average log
side-scatter. Regressing fold change in log intensity on the average log side-scatter,
generated a slope for each sample-pair per replicate, resulting in three slopes for each
GFP-fusion strain. These slopes were shown to have high reproducibility (please see
supplemental materials for more details).
The median mi is calculated for each gene (GFP) i, over the three slopes. An
approximate z-statistic is obtained for every sample by subtracting each mi from its mean
over 3941 genes and dividing the difference by the standard deviation of mi over all 3941
genes. This z-statistic is the numerical value for SDI. Similarly, SDI for exponential
phase was obtained, where fold change was calculated by subtracting average log
intensity in SP from the average log intensity in exponential phase, followed by linear
regression.
3.2.4 k-means clustering
k-means clustering was performed on each dataset using the ratio of average log
intensity to average log forward-scatter. The number of clusters for k-means was prespecified as 20 (the number of clusters was tested from 5 to 100 in increments of 5 with
very similar results). The average profile for each cluster was computed, followed by
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visual identification of clusters with broad or jagged profiles. These clusters were
expected to contain proteins with multiple populations. This analysis identified one
cluster of 80 samples from stationary phase, and one cluster of 99 samples from
exponential phase. Samples from these clusters were compared against candidate
heterogeneous samples from other methods.
3.2.5

Average fold change
Average fold change is frequently used in microarray data. Similar to SDI, but

using limited to a single dimension (fluorescence intensity), the average log fluorescence
intensity over all cells (events) from each GFP strain was obtained for each sample for
both SP and exponential phase. Next, for every GFP, we subtracted the average log
intensity from exponential phase, from the average log fluorescence intensity from SP,
and generated the average fold change measure, for each sample. We define the average
fold change for every gene i as the median over all 3 samples of the average fold change
measure.

3.2.6 Identification of GFP strain lists and GO process categories
Four approaches were used to identify proteins with heterogeneous samples: SDI,
visual identification, k-means clustering and average fold change. For visual
identification of two-peak samples approximately 8000 samples were examined using
IDLQuery. Two sample lists were generated: 147 SP, two-peak samples (SPV) and 45
exponential phase two-peak samples (EPV). For k-means clustering two sample lists
were generated: (SKM) with 80 SP samples and (EKM), with 99 exponential phase
samples. Lists generated by SDI measure (SDI) and average fold change (AFC) were
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compared with lists generated by the other two approaches for Gene Ontology (GO)
process enrichment. Lists from SDI were generated by sorting according to decreasing
SDI measure and then selecting top n samples. n depended on the type of comparison
(See Results). Similarly lists from average fold change were obtained.
After sample lists were generated, each list was evaluated using GO Term Finder
(www.geneontology.org), available at Saccharomyces Genome Database. For each list,
p-values for GO biological process categories were obtained and the most significant
categories of each list were selected with their respective p-values (for more details about
p-value generation, please see supplemental materials).

3.3 RESULTS
3.3.1 SDI and two-peak plots
The histogram distribution obtained from IDLQuery shows the distribution of
fluorescence intensity of two yeast GFP-fusion strains from stationary–phase cultures
(Fig. 1).

Figure 1 - Histograms of flow cytometry output comparing log fluorescence intensity vs.
number of events for two yeast GFP-fusion strains in SP. CIT1 shows a two-peak
distribution whereas ALG14 shows a single peak.
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Similarly, the histogram distribution of fluorescence intensity of the same two yeast GFPfusion strains from exponential–phase cultures is shown (Fig. 2).

Figure 2 - Histograms of flow cytometry output comparing log fluorescence intensity vs.
number of events for two yeast GFP-fusion strains in exponential phase. CIT1 and
ALG14 show single peak distributions.

These were the types of outputs used to visually detect samples with two peaks, i.e.,
bimodal distribution of fluorescence intensity. The same yeast strains from both
exponential and stationary phases were compared using two scatter plots: one displaying
fluorescence intensity as a function of side scatter (Fig. 3), and the other displaying the
fold change in fluorescence intensity as a function of side scatter (Fig. 4). As can be
seen, fluorescence intensity of CIT1 changes at a higher rate in SP than in exponential
phase. This difference is captured by the SDI measure (Fig. 4), which is high (0.81) for
CIT1 and close to 0 for ALG1 (0.02). Through this analysis, we determined that a
significant slope is strongly associated with strains that have bimodal distributions of
fluorescence intensity. This association between large slope values and bimodal intensity
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distributions is exploited by SDI to detect heterogeneous cell populations in a highthroughput fashion.

Figure 3 - Scatter plot of log side-scatter vs. log fluorescent intensity. Triangles
represent the average log fluorescence intensity in SP and circles represent the average
log fluorescence intensity in exponential phase. To assure statistical significance, each
bin in the both plots was selected only if it had at least 50 events in both datasets.

Figure 4 - Regression scatter plot of log side-scatter vs. log fold-change in fluorescent
intensity. Triangles represent average fold change in log intensity between stationary and
exponential phase. To assure statistical significance, each bin in the both plots was
selected only if it had at least 50 events in both datasets.

To determine the significance of the slope in figure 4, a weighted linear
regression, where each bin is assigned the weight which is the minimum of the number of
cases for that bin, between SP and exponential. Similarly, we estimate the weighted of
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the slope, and by divide the slope by its standard deviation, to obtain a t-statistics and its
corresponding p-value. However, gene lists produced based on ranking by slopes turned
out to have far better enrichment, than gene lists produced by ranking by t-statistics, and
thus we chose to rank by slope (which is the same as ranking by t-statistics, but assuming
all slopes have the same variance).
The modeling of the fold change for each bin as a function of side-scatter can be
further improved by assuming a non-linear association. This non-linear association is
suited to model saturation regions which fold change will tend to be constant for high
levels of side-scatter, such as the 5 triangles in the extreme right of figure 4. One simple
non-linear function to model the relation between log-fold change in intensity and log
side-scatter is f(x) = a( 1 – exp(– (bx+c)) ), where x is the log side-scatter which has an
upper bound (asymptotic) at a, and will look like the line a(bx+c) near the region in
which bx+c is close to zero, that is, in the neighborhood where x is close to –c / b. This
function also has an interesting property which is that it also models the local slope (slope
in this neighborhood), which is equal to ab and is a non-linear version of SDI for every
GFP, and would also be used to rank GFPs and produce gene lists. However, in this
dataset, genes lists generated by ranking genes by ab was very similar to gene lists
generated by ranking by the linear SDI, and therefore no additional benefit was observed
for using this non-linear model.
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3.3.2 Biological process enrichment
Enrichment performance using Gene Ontology (GO) biological process categories
was obtained for SP visual two peak list (SPV, 147 GFP-fusion strains) and same sized
lists (147 GFP-fusion strains) generated using two SDI measures SDI_SS (which uses
side-scatter), SDI_FS (which uses forward-scatter) and average fold change (AFC) for SP
(Table 1). Since SDI_FS was very similar to SDI_SS, after table 2 until the end of this
chapter, we user only to SDI_SS, and for simplicity we will refer to it as SDI. Also for
simplicity, all p-values from the tests will be one-tail p-values until the end of this
chapter.
Table 1 - Gene Ontology biological process enrichment comparison for stationary visual
two-peak list (SPV), SDI_SS (SDI side-scatter), SDI_FS (SDI forward-scatter) and
(AFC) of the same size (147 samples).
SPV

GO CATEGORY
generation of precursor metabolites and energy
oxidative phosphorylation
cofactor metabolic process

7.9E‐21
1.6E‐17
1.4E‐13

AFC

SDI_SS

6.8E‐15
4.0E‐19
1.0E‐12

3.1E‐32
2.5E‐24
2.1E‐18

SDI_FS
8.4E‐30
2.5E‐24
2.0E‐15

GO enrichment of SDI_SS and SDI_FS lists was significantly superior compared to
SPV and AFC. Similarly, GO enrichment was generated for the k-means list (SKM) and
same size lists (80 GFP-fusion strains) using SDI and AFC (Table 2). GO enrichment of
SDI_SS and SDI_FS lists was significantly superior to SKM and AFC.

Table 2 - Gene Ontology biological process enrichment comparison for stationary kmeans (SKM), SDI_SS (SDI side-scatter), SDI_FS (SDI forward-scatter) and (AFC) of
the same size (80 samples).
SKM

GO CATEGORY
generation of precursor metabolites and energy
oxidative phosphorylation
cofactor metabolic process
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1.1E‐08
1.4E‐10
3.1E‐07

AFC
1.6E‐11
1.4E‐13
7.0E‐12

SDI_SS
2.7E‐24
2.7E‐22
2.2E‐17

SDI_FS
5.7E‐27
2.0E‐20
4.5E‐15

GO enrichment of SDI_SS and SDI_FS lists was significantly superior compared to SKM
and AFC. In Table 3 we show the significance between the number of genes from SDI,
compared to SPV and AFC, for results from Table 1.
Table 3 – Number of genes in each GO biological process category present in the gene
list using different approaches (SDI, SPV, AFC). In column 6 we have the p-value under
the normal approximation for the hypergeometric distribution that SDI is significantly
greater than SPV and similarly in column 7 we have the p-value that SDI is significantly
greater than AFC.
GO CATEGORY
GFP in cat
generation of precursor meta
140
oxidative phosphorylation
30
cofactor metabolic process
134

SDI
45
21
32

SPV
35
17
27

AFC SDI.vs.SPV
29
18
26

5.0E‐04
2.5E‐03
4.6E‐02

SDI vs. AFC
6.9E‐08
1.8E‐02
2.2E‐02

In Table 4 we show the significance between the number of genes from SDI, compared to
SPV and AFC, for results from Table 2.

Table 4 - Number of genes in each GO biological process category present in the gene
list using different approaches (SDI, SKM, AFC). In column 6 we have the p-value
under the normal approximation for the hypergeometric distribution that SDI is
significantly greater than SKM and similarly in column 7 we have the p-value that SDI is
significantly greater than AFC.
GO CATEGORY
GFP in cat
generation of precursor meta
140
oxidative phosphorylation
30
cofactor metabolic process
134

SDI
31
17
24

SKM
15
10
14

AFC SDI.vs.SKM SDI vs. AFC
19
12
19

7.2E‐13
2.0E‐11
7.7E‐06

5.5E‐08
1.2E‐06
1.5E‐02

We did a similar GO enrichment analysis for lists from exponential phase cultures.
However, the enrichment performance for all three lists was similar and much lower than
lists from SP. For example, p-value for the best category of visual exponential two-peak
list was > 5.7E-05, of k-means list was > 5.0E-04, of average fold change was > 5.0 E-04
and for SDI > 1.8E-4. These results suggest that heterogeneous cell populations are more
likely to occur in stationary than in exponential phase cultures.
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3.3.3 Marginal enrichment
Marginal enrichment comparisons between two lists of the same size are used to
identify the enrichment of each list after excluding the overlap between them, measuring
the exclusive enrichment of each list. Excluding from SDI the samples present in the
overlap of SDI and SPV resulted in a list of 52 samples, which we call SDI–SPV.
Similarly, excluding the same overlap from SPV resulted in a same size list called SPV–
SDI. Next we selected a random list of the same size as a control for enrichment
comparisons. The three lists were submitted to GO Term Finder and enrichment for the
most significant 20 categories of each list was ranked by

–log(p-values) and

compared. Marginal enrichment was also compared between SDI and AFC with lists of
size 95 and similarly, comparisons between SDI and SKM with list sizes of 46 samples
were performed (Fig. 5). SDI–SPV list is more enriched than SPV–SDI list for all
category ranks. SDI–AFC list is more enriched than AFC–SDI for all category ranks.
This is illustrates the benefits in using two-dimensional fold change, which is SDI,
compared to using a single dimensional fold change, which is AFC. Furthermore, SDI–
SKM shows a high level of enrichment, whereas SKM–SDI shows enrichment no
different from random.
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Figure 5 – (1) Line plot comparing SP marginal lists, SDI vs. visual 2 peak list (SPV).
Standard errors for the –log(p-value) from random lists are not shown since they are very
small. (2) Line plot comparing SP marginal lists, SDI vs. average fold change (AFC). (3)
Line plot comparing SP marginal lists, SDI vs. k-means (SKM). Standard errors for the –
log(p-value) from random lists are not shown since they are very small.

3.3.4 Intersection analysis of compared approaches
We compared the overlap between lists generated by each approach for
heterogeneous sample detection. We used a p-value cutoff of 0.01 to generate an SDI list
of 78 samples. Next, a triple overlap between this SDI list, stationary-phase two-peak
SPV and stationary-phase k-means SKM lists was obtained, which had 33 samples (Fig.
5).
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The overlap between SDI and SPV (39) excluding the triple overlap is greater than
the overlap between SDI and SKM (1) excluding the triple overlap, and similarly, greater
than overlap between SPV and SKM (9) excluding the triple overlap. This suggests a
higher similarity between SDI and SPV. Because SPV was generated via visual analysis,
and deemed to be of high quality, the high similarity of SDI list further indicates SDI to
be a reliable approach of detecting heterogeneous samples.

3.3.5 Microscopic examination of gradient-separated cells
In order to provide a stronger validation of our candidate heterogeneous samples, we
performed phenotypic analysis using density separation and microscopy, of 35 high
confidence candidates. These 35 samples included the triple overlap (33 samples) of all
three approaches and two additional samples corresponding to second and third highest
SDI measures (the sample with highest SDI measure was already in the triple overlap).
Density separation of GFP-fusion strains for each of the 35 samples resulted in an
upper and lower fraction in stationary phase. For every sample both upper and lower
fractions were isolated, giving rise to 70 cultures: 35 cultures containing high-density
cells and 35 cultures containing low density cells, corresponding to 35 GFP-fusion strain
pairs. For simplicity we will use the term GFP-fusion strains instead of GFP-fusion
strain pairs. Next, each GFP-fusion strain was compared with visual microscopy to
identify differences in GFP-fusion localization among the high and low density cells.
This resulted in 20 GFP-fusion strains with visual differences in fluorescence between
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their corresponding high and low density populations. Majority of these 20 strains had a
high SDI score (pvalue < 1.1E-4).
In order to provide additional comparison of the approaches, samples that were
exclusively identified (Fig. 6) by each approach were analyzed microscopically.
Specifically, we selected 5 (out of 37), 5 (out of 67), and 5 (out of 6) samples uniformly
at random from two peak visual analysis, k-means and SDI, respectively. After visual
inspection, we used the following classification for each GFP-fusion strain: 1 if there was
clear visual fluorescence difference, and 0 if there was no difference (Table 5). SDI
showed differences in fluorescence in all 5 GFP-fusion strains, followed by SPV with 3
differentiated GFP-fusion strains out of 5.

None of the samples from SKM had

differences in fluorescence.
Inspection of GO categories for the list of 35 samples identified ‘Carboxylic acid
metabolic process’ to be one of the highly significant categories. Interestingly, all strains
from our list that were annotated with Carboxylic acid metabolic process (9 out of 35)
had visual differentiation in fluorescence intensity. This was highly significant (p-value
equal to 1.4E-8) and suggests that
proteins involved in Carboxylic acid metabolic process are highly likely to form
heterogeneous populations.
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SDI
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37
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33
9

38
67

SPV
Figure 6 - Venn diagram of the overlaps using SDI, SPV and SKM. Overlap between
SPV and SDI is much higher than overlaps with SKM.

Table 5 - Visual microscopy identification of fluorescence differentiation of nonoverlapping GFP-fusion strains. A ‘1’ represents visual differentiation in fluorescence
intensity and ‘0’ represents no differentiation.

Random sample of non-overlapping genes (GFP-fusion)
SDI
Diff
SPV
Diff
SKM
Diff
TEF1
URA1
TDH3
ATP10
SDH4

1
1
1
1
1

ATP1
MES1
PRT1
ABF2
PRE3

1
0
0
1
1
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MDV2
UBC1
NMD4
PET18
ENP1

0
0
0
0
0

3.4 DISCUSSION
Heterogeneous cell populations can be detected using different methods, with every
method having its own limitations.

For example, gradient separation can identify

heterogeneous cells populations based on density, but not if heterogeneous populations
cannot be separated on the basis of density. Visual detection of two-peak samples can
detect heterogeneity from a single condition, but it is not clear how to detect
heterogeneity across two conditions. Further, this approach requires manual inspection,
which does not scale when data from multiple conditions are available.
SDI identifies heterogeneous cell populations, by incorporating the relative change in
fluorescence intensity between two conditions. This makes SDI suited to detect
heterogeneity between two conditions. The strength of SDI relies on the assumption that
different subpopulations within a heterogeneous population exhibit different relations
between fluorescence intensity and side-scatter (forward-scatter). Based on this
assumption, SDI uses a linear regression as a computationally efficient way to detect
differences in these relations.
SDI requires data from two conditions. However, if heterogeneity is much larger in
one of the two conditions, SDI is likely to work as well as an approach that looks at a
single condition at a time (two-peak analysis or k-means). This was true for our setup,
where most of the meaningful heterogeneous candidates were in SP and not in
exponential phase. The marginal enrichment analysis showed that most of the enrichment
of SPV lists was due to the overlap between SDI and SPV lists.
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3.5 CONCLUSION
In this paper, we have described a scalable approach for detecting heterogeneous
populations from high-throughput flow cytometry data. Sample lists obtained from SDI
measures had superior enrichment compared to lists obtained from visual two-peak
distributions, average fold change and k-means clustering. The superior enrichment of
SDI was also supported by our marginal enrichment analysis, where most of the
enrichment of other approaches was due to the overlap between these lists and SDI list.
Moreover, gradient-separation followed by visual microscopy, showed that samples
identified by SDI were highly likely to have differences in GFP localization in high and
low density cells.
SDI currently performs linear regression of the fold change in log intensity to side
scatter. However, for some of the GFP-fusions strains, this linear relationship does not
hold. Extending SDI to perform a piece-wise linear or non-linear regression is an
important direction of future research.
As high throughput flow cytometry becomes more routine with many thousands of
measurements per minute, approaches that allow rapid characterization of samples will
become increasingly important. The SDI approach provides a simple, scalable way to
identify strain heterogeneity that can identify important biological differences in high
throughput data that might not otherwise be accessible for evaluation.
At this point, we do not completely understand all the factors that govern
heterogeneity within a cell population. A comprehensive study involving more complex
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experimental designs over many conditions in concert with approaches like SDI will be
instrumental in improving our understanding of the cause and benefit of heterogeneous
cell populations.
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3.7. SUPPLEMENTAL MATERIALS
3.7.1 Growth conditions
Individual strains from the Yeast GFP Collection that were constructed from the
base strain ATCC 201388: MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 (S288C) (Brachmann,
Davies et al. 1998) were replicated into 96 well plates containing YPD + A (2% yeast
extract, 1% peptone, 2% glucose, 0.04 mg/mL adenine, and 50 μg/ml ampicillin; (Rose
1990) using pin tools. The plates were covered with Breathe Easy sealing membranes
(Sigma Aldrich cat #380059) and the strains were cultured at 30°C with aeration either
overnight (for exponential growth) or for 7 days (for stationary-phase growth).
3.7.2 High-throughput flow cytometric screening
Three steps were used to prepare the samples for high throughput screening.
First, dilution plates were prepared by transferring 90µL of peptide dilution flow buffer
(30mN HEPES*1/2 Na, 110mM NaCl, 10mM KCl, 1mM MgCl2*6H2O) into each well
of the 384-well plates (Greiner Bio-one Cat #781280) using the Biomek NX

MC

(Beckman Coulter, Fullerton, CA.) liquid handling robot. Second, 10µL of each yeast
strain were transferred from the 96-well growth plates into 3 adjacent wells of the 384well dilution plates using the Biomek NXS8 (Beckman Coulter) liquid handling robot.
This step created a 1:10 dilution and generated three technical replicates for each sample.
The 4th, 8th, 12th, 16th, 20th, and 24th columns of the dilution plates do not contain samples,
just buffer alone. These columns serve as a wash well in between different samples to
minimize any sample carryover.

Third, the cells were sampled with a HyperCyt®
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(Edwards, Oprea et al. 2004; Young, Bologa et al. 2005) autosampler controlled by
HyperSip software and interrogated for GFP fluorescence with a CYAN ADP (Dako
Cytomation, Ft. Colllins, CO) flow cytometer using excitation at 488 nm and collection
of fluorescent emissions with a 530/40 nm filter set. The data were processed using
IDLQuery software and the median channel fluorescence for each sample was calculated
and used for subsequent analyses.

3.7.3 Flow dataset
Approximately 4000 GFP were used in both SPand exponential phase generating
two datasets. In each dataset, three technical replicates were generated for every GFP
where each GFP has approximately 30,000 events. After applying a filter in which we
excluded GFP with missing data in either exponential or stationary phase, there were a
total of 3941 GFP for used in both stationary and exponential datasets.

3.7.4 Reproducibility analysis between biological samples
In order to make an evaluation on the quality of the data, an additional biological
sample was generated approximately 4 weeks after the completion of the initial
experiment, by selecting at random four plates of 96 GFP each.

This additional

biological sample also had 3 technical replicates. For both stationary and exponential,
the two biological samples were joined having a total of 384 GFP, 3 technical replicates
from the first sample and 3 technical replicates from the second sample. Each technical
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replicate contained for each GFP, the average log fluorescence intensity over thousands
of events, which were then correlated between biological samples. All the Spearman
correlation coefficients were over 0.90 and thus we can state the high reproducibility of
the average fold change.

3.7.5 Reproducibility analysis between technical replicates
Correlations using slopes from SDI were performed between the three technical
replicates to show the reproducibility of both side-scatter slopes and forward-scatter
slopes over the total 3941 GFP. Respective Spearman correlations for slopes from each
pair of replicates were 0.966(rep1, rep2), 0.971(rep1, rep3) and 0.967(rep2, rep3). Given
that all Spearman correlations were above 0.90, we can state the high reproducibility of
the slope used in SDI.

3.7.6 SDI Algorithm
Generating the groups:
1.

Sort the exponential- and stationary-phase datasets by side-scatter and define k,
e.g.,

k = 50, equally populated groups, defined over the set of all side-scatter events.
2.

Assign all events from exponential- and stationary-phase samples to their
corresponding groups.
For every sample j (GFP-strain):
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3. Calculate FIsij as the average of log2 of the fluorescent intensity of each event
from the

SP set, for group j and sample j, and let FIeij be the analogous value for the

exponential phase set.
4. Combine corresponding samples from SP sample j and exponential phase sample
j into sample-pairs, referred to sample-pair j.
5. Three sample-pairs, one per technical replicate. For every sample-pair, the fold
change in log-intensity was calculated for each group by taking the difference in
average log intensity between them.
6. Calculate ∆FCij = FIsij – FIeij, the average fold change for group j from samplepair j.
7. For every sample-pair i, select groups with both number of events ≥ 50 in SP
sample i and number of events ≥ 50 in exponential phase sample i. In the end,
each sample-pair i will have a total of k’iI selected groups, where k’i ≤ k.
8. Calculate the average log2 in side-scatter for each corresponding selected groups,
denoted as xi1, xi2,…, xik’. Let array X denote the set containing these values.
9. Let ∆FCi1, ∆FCi2,…, ∆FCik’ be the array Y of fold-change values for the selected
groups for sample j.
10. Regress Y on X and generate slopei, the slope for sample j.
Combining the sample-pairs for the three replicates from each GFP-strain i:
11. Three slopes are generated, one for each j replicate sample-pair.
12. Calculate the median of the slopes over all three sample-pairs mij.
13. An approximate z-statistic is obtained for every sample by subtracting each mij by
its mean over 3941 samples and dividing the difference by the standard deviation
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of mij over all 3941 samples. This z-statistic is the numerical value for GFP-strain
i which is called SDIi..

3.7.7 GO Term Finder settings
The main settings used for GO term finder are: ORF’s only, no ‘dubious’
categorized genes, ‘manually annotated’ with a background set of genes being the set of
3941 ORF’s corresponding to their respective GFP (http://db.yeastgenome.org/cgibin/GO/goTermFinder.pl).

When calculating the p-value the option ‘no Bonferroni

adjustment’ was chosen. Ontology was set to ‘process’ and the cut-off level for the
category p-values was 0.01(default value).
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Chapter 4 - CRAM

Calibration Regression Analysis of Microarrays
Osorio Meirelles1, Sushmita Roy2 and Margaret Werner-Washburne1

4.0 ABSTRACT

Background: With the advent of genomics, there has been a rapid increase in the use of
two and one-color microarrays, used to measure mRNA abundance for the entire genome.
Variability in microarray analysis undermines its utility in identifying the entire subset of
differentially expressed mRNAs. Recent microarray studies have shown that, although it
is assumed that variances are constant for every hybridized spot within a microarray,
variances may differ for each biological sample analyzed (Ritchie, Diyagama et al. 2006).
Another common assumption is that log-intensity values for any given gene have a
Normal distribution.

For many datasets, both assumptions have been shown to be

incorrect, resulting in distortions in the significance when testing for differential
expression of each gene (Bar-Even, Paulsson et al. 2006; Wentzell, Karakach et al. 2006).
Approach: To overcome the limitations of existing approaches in identifying significant,
differentially expressed genes, we have developed a novel unsupervised statistical
approach called Calibration Regression Analysis of Microarrays (CRAM) that uses a
combination of empirical Bayes and regression calibration. The main novelty of our
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approach is the modeling of gene expression variances as a function of the log-intensity
within each sample. Another version was later developed CRAM-GS in which the
association between genes is captured using an adjusted gene correlation measure.
Results: CRAM was compared to four existing approaches for identifying differentially
expressed genes. Performance was based on the ability to identify co-regulated genes in
the same Gene Ontology process. CRAM exhibited a marginal improvement in GO
process enrichment compared with the other approaches. To the original datasets, three
more were included in which the later version CRAM-GS, showed a significant
improvement compared to CRAM, suggesting a major additional benefit of incorporating
gene correlations into the model. All versions of CRAM were two orders of magnitude
faster than the existing approaches. Overall, CRAM provides an adaptive,
computationally efficient approach for accurate identification of differentially expressed
genes.
Keywords — Empirical Bayes, microarrays, regression, measurement error,
calibration.

4.1 INTRODUCTION
Accurate identification of differentially expressed genes, detected as changes in
mRNA abundance, is crucial for extracting biological relevance from microarray data.
Methods for identification of differentially expressed genes typically use some type of tstatistic, requiring the estimation of both expected log-intensity values across samples for
expression of every gene, and the variance of the expected log-intensity for the same
genes.
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In this paper, we define gene-expression variance for one microarray spot as a
product of sample-specific variance and gene-specific variance (Ritchie, Diyagama et al.
2006).

Sample-specific variance results from technical or measurement error. Gene-

specific variance is described as the variance contribution attributed to biological
expression of each gene or the deviations from the expected log-intensity across samples.
Different methods make different assumptions for estimating the gene-specific
variance and sample-specific variance. Gene-specific variance is commonly estimated
using log ratios for each gene, across all samples. However, when datasets have a small
number of arrays, gene-specific variance is often underestimated, resulting in inflated tstatistics (Smith 2004).
Many approaches improving gene-specific variance estimators have been developed
to address the problem of distorted t-statistics (Efron B 2001; Tusher, Tibshirani et al.
2001; Lonnstedt and Speed 2002; Broberg 2003; Smith 2004; Kristiansson, Sjogren et al.
2005; Kristiansson, Sjogren et al. 2006; Ritchie, Diyagama et al. 2006; Astrand, Mostad
et al. 2007; Sjogren, Kristiansson et al. 2007; Astrand, Mostad et al. 2008). These
approaches assume that the expected expression values have a Normal distribution.
However, in microarray data from heterogeneous biological samples, where each sample
corresponds to a different subject, this is unlikely to be true. In heterogeneous samples,
the Normality assumption is typically violated because of large variations between
samples, producing inaccurate gene-specific variance estimates, and thus, distortions in tstatistics estimates.
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Sample-specific variance, although usually distinct for each sample, is usually
modeled by assuming it is constant for every gene within each sample. Unfortunately,
sample-specific variance is often dependent on the intensity level of each gene (BarEven, Paulsson et al. 2006; Wentzell, Karakach et al. 2006). To address the limitations of
both sample-specific variance and gene-specific variance assumptions, we have
developed a novel statistical algorithm. Calibration Regression Analysis of Microarrays
(CRAM) models both sample- and gene-specific variance based on analysis of the data,
by combining empirical Bayes (Baldi and Long 2001; Lonnstedt and Speed 2002; Smith
2004; Kristiansson, Sjogren et al. 2005; Kristiansson, Sjogren et al. 2006; Sartor,
Tomlinson et al. 2006; Astrand, Mostad et al. 2007; Sjogren A 2007; Astrand, Mostad et
al. 2008) and regression calibration (Spiegelman, McDermott et al. 1997; Schneewei B
2005) to accurately identify differentially expressed genes.
CRAM was compared with four existing approaches:

Locally moderated

weighted t-statistics (LMW) (Astrand, Mostad et al. 2008), Weighted moderated tstatistic (WAME) (Smith 2004; Kristiansson, Sjogren et al. 2005; Kristiansson, Sjogren
et al. 2006; Astrand, Mostad et al. 2007; Sjogren A 2007), fold change (FC), and
ordinary t-statistic (t), on four yeast microarray datasets (Aragon, Rodriguez et al. 2008).
Performance was measured using Gene Ontology (GO) process
enrichment(GeneOntology ; GOTermFinder). CRAM showed a marginal enrichment
improvement compared to other approaches. Additionally, CRAM is highly
computationally efficient compared with other methods, scoring a dataset of 88 samples
in less than one second as compared with several minutes for other approaches.
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In addition to capturing associations between microarray samples, the more recent
CRAM-GS captures associations between genes. The underlying assumption is that since
every gene belongs to a pathway containing one or more genes, a differentially expressed
gene should have a strong level of association with at least some other gene. Similarly to
correlating samples, a gene highly correlated with another gene is an indication of
confidence in the expression values of that gene. For this reason, the quantification of
gene correlations will prove to be a significant improvement over CRAM. CRAM-GC is
also computationally very efficient, making it applicable to large microarray datasets.

4.2 RELATED WORK
A basic model for identifying differentially expressed genes estimates the expected
log-intensity by calculating the average of log-intensity across all samples. Similarly,
gene-specific variance is estimated by calculating the variance of log-intensity values
across all samples, generating a standard t-statistic for every gene. This model often
underestimates variances in log intensity when the number of samples is small, leading to
overestimated t-statistics. To address the issue of inflated t-statistics, many methods have
been developed in recent years.
Penalized t-statistics type approaches, add a constant to the gene standard deviation
across samples, whereas the posterior odds t-statistic, also known as B-statistics, adds a
constant to the gene expression variance, providing a better solution (Efron B 2001;
Tusher, Tibshirani et al. 2001; Lonnstedt and Speed 2002; Broberg 2003). The posterior
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odds t-statistic method was later extended into the moderated t-statistic (Smith 2004).
However, moderated t-statistics does not account for sample-specific variance.
Moderated t-statistic was extended to Linear models for microarray data,
LIMMA, with the assumption that each array had a constant but distinct sample-specific
variance (Ritchie, Diyagama et al. 2006). LIMMA is also a software application part of
the Bioconductor Projects web page (LIMMA). LIMMA however, assumes
measurements from biological samples are independent, which is not true for many
datasets (Kristiansson, Sjogren et al. 2005).
Weighted moderated t-statistic (WAME), overcomes the measurement
independence assumption by introducing a correlation structure between samples.
Locally moderated weighted t-statistic (LMW), also part of the PLW software
application, is an improved version of WAME that incorporates the modeling of genespecific variance as a function of the expected intensity level of each gene (PLW-Astrand
2008).
All three approaches, LIMMA, WAME and LMW use some form of moderated
t-statistic based on the estimation of gene expression variance using an independence
assumption between gene-specific variance and sample-specific variance. With this
independence assumption, gene expression variance can be defined as a product of genespecific variance and sample-specific variance. Similarly, our method estimates gene
expression variance under the same independence assumption, however, we allow the
sample-specific variance to vary within each sample as a function of intensity levels for
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every gene in the sample. The independence assumption between gene-specific variance
and sample-specific variance is also used in CRAM-GS.

4.3 METHODS
4.3.1 Datasets
A total of four yeast cDNA microarray datasets were used to validate our approach
(Aragon, Rodriguez et al. 2008). Arrays are assumed to have undergone a standard
microarray normalization process, followed by natural logarithm transformation on all
expression values, generating a log-intensity value for every gene in every array. Each
dataset measures gene expression change from two yeast cell populations, quiescent and
non-quiescent, separated from stationary phase cultures using density centrifugation.
The datasets used are the same as used in chapter 2, with the main difference being
that the datasets described and referred to as 1 to 4, correspond to the datasets in chapter
2 from 2 to 5. Dataset 1 has 80 microarrays from the quiescent population and 80 from
non-quiescent, where each microarray measures the gene expression profile of a single
yeast deletion mutant. Dataset 2 is similar to dataset 1 with 176 microarrays from 88
mutants. Datasets 3 and 4 have 32 and 20 microarrays respectively, corresponding to 16
auxotrophic parental (BY4742) strains and 10 wild type (S288C) strains.
Datasets 1 and 2 are said to be heterogeneous since they have very dissimilar
samples due to the genetic differences, resulting in high biological variability. Datasets 3
and 4 are said to be homogeneous datasets in which samples are biological replicates and
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therefore are expected to have lower biological variability than datasets 1 and 2. We
excluded genes with >80% missing values in any dataset producing a total of 5649 genes
in all datasets.
For each biological sample we subtracted the log intensity measurements in the nonquiescent microarray from the quiescent microarray. Next, this difference in log-intensity
was adjusted by subtracting the mean log-intensity difference over all genes, such that the
mean of log-intensity difference was equal to zero. We will refer to differences in logintensity as delta log-intensity throughout this article.

4.3.2 Method Overview
Differentially expressed genes are typically identified using t-statistics, which
require the estimation of the variance of every gene. Gene expression variance is a
product of two entities: gene-specific variance and sample-specific variance (Ritchie,
Diyagama et al. 2006). Gene-specific variance is defined as the variance contribution
attributed to each individual gene, and sample-specific variance is defined as the variance
contribution of each individual sample.
Calibration Regression Analysis of Microarrays (CRAM) is a novel approach for
identifying differentially expressed genes that is based on three themes:
(a) gene-specific variance is treated as a weighted average between the variance
estimate of a gene and the average of these variance estimates over all genes,

91

(b) sample contribution of each to the gene expression variance is weighted
according to the quality of each sample, and
(c) sample-specific variance is not constant, but rather depends on the intensity level
of the genes within the sample.
CRAM first uses a linear regression model to predict a sample using the remaining
samples. Next, the predicted sample is regressed using the original sample where a slope
is generated. Using an Empirical Bayes approach, slopes are transformed into weight
parameters, inversely proportional to the sample-specific variances. We extend this
weight estimating procedure to gene subsets within each sample, increasing the precision
of the weights and therefore the accuracy of expected delta log-intensity.

4.3.2.1 Notation
Let k represent the number of biological samples in a dataset and n the number of
genes.
Denote Xj = {x1j, x2j, ... , xnj} as the set of delta log-intensity values for every gene i in
sample j. A dataset with k samples will be represented as the set {X1, X2,…., Xk.}.
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4.3.3 Linear model
Let xij, the observed ∆log-intensity value for gene i in sample j be written as

xij = τi + eij ,

for i = 1,2,…, n and j = 1,2,…,k

(4.1)

where τi is N(µi , σi2 )-distributed random variable, representing the unknown measure of
the expected ∆ log-intensity for gene i, µi is a known prior expected ∆ log-intensity and
σi2 is the unknown variance of ∆ log-intensity for gene i. The random variable eij is an
unknown measurement error for gene i in sample j, assumed to be N(0, σi2/wj)distributed, which variance is proportional to the variance of τi by a factor equal to

1/wj. We also assume that τ1 , τ2 , …, τn are independent, that the eij are independent for
all i and j, and that the τi and eij are independent for all i and j. Thus, since the sum of
normally distributed random variables is itself normally distributed, we see that the
random variable xij is N(µi ,σi2 + σi2/wj)-distributed, or equivalently,
N(µi ,σi2 (1+ wj )/wj)-distributed.
The identification of differentially expressed genes requires us to perform a
hypothesis test for every gene i:

H0:

τi

=0

τi

≠ 0

vs.
H1:
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If H1 is true, gene i is said to be differentially expressed, and if H0 is true gene i is said
not to be differentially expressed. For example, in datasets 1 to 4, if H1 is true, a gene i
is said to be differentially expressed in relation to Q vs. NQ. Similarly, the same idea
applies to any differences between two conditions. Summarizing, we assume random
variables τi and eij to have the prior distributions

τi ~ N(µi, σi2 )

and

eij ~ N(0, σi2/ wj )

(4.2)

,

where τi and eij are mutually independent, eij is independent for gene i and sample j, σi2
≥ 0 is the unknown variance of τi , µi is the known prior expectation for τi , and wj > 0 is
2

an unknown positive parameter for sample j. The parameter σi is defined as the genespecific variance, whereas the sample-specific variance is defined as 1/ wj. Thus, the
variance of eij is σi2/ wj, the product of gene-specific and sample-specific variances. In
addition, the set of unknown expected ∆ log-intensity values τ1 , τ2 , …, τn are assumed to
be independent, which is equivalent to assuming uncorrelated genes or more formally,
2

that the knowledge of parameters τi’, σi’ for any gene i’ does not influence (or change)
the conditional distribution of τi for gene i. Although this is a simplistic assumption since
it is known that many genes are often correlated, this assumption is still often used in
2

most of the current models. We now need to estimate the gene parameters τi, σi , and the
sample parameters w1, w2,…, wk , which we describe in the next subsection.
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4.3.3.1 Estimating τi
From (4.1) and (4.2):
P(xij | τi = λi) ~ N(λi , σi2/wj).

(4.3)

The posterior distribution τi | wj , xij is also a Normal distribution
2

P(τi | xij) ~ N( (µi + wj xij )/(1+ wj) , σi /(1+ wj ) ).

(4.4)

For proof please see supplemental materials 4.7.2.
From the expression above, if we do not know the value for the prior µi, we set it equal to
zero, which is the mean of the normalized expression values xij over sample j. When wj is
2

equal to zero, the posterior variance is equal to σi (the prior variance of τi) implying that
the value xij has no useful information since the posterior mean is shrunk to µi (the prior
expectation of τi). When wj becomes large, the posterior variance becomes close to zero,

wj/(1+ wj) becomes closer to one and thus the posterior mean becomes close to xij,
indicating a large confidence in the value xij as an estimate of τi and thus, the influence of

µi in estimating τi becomes negligible. So when wj is small (large sample-specific
variance), there is low confidence in the observed xij values in sample j whereas when wj
is large, there is high confidence in these values. Denoting W = (w1, w2, … ,wk) and Xi

= (xi1 , xi2, … , xik), after observing all samples and assuming independence among
samples Xj, we generalize the posterior distribution

P(τi | Xi) which has a Normal distribution with mean ui ,where
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ui = E(τi | Xi) = (µi +

k

∑
j =1

k

wj xij )/ (1+ ∑ wj )

(4.5)

j =1

is also the maximum likelihood estimator of τi. Furthermore, µi parameters can be very
useful if they were obtained as the output (a measure of expected gene expression) from a
previous experiment performed under very similar conditions, which could potentially
largely improve the precision of the current model. Considering that in our datasets we
do not know the prior µi parameters, we set all of them equal to zero, in all datasets.
However, we chose to keep the µi parameters in most equations, in order to describe the
most general case. Setting all µi equal to zero, equation (4.5) simplifies to
k

k

j =1

j =1

ui = E(τi | Xi) = ( ∑ wj xij )/ (1+ ∑ wj ) .
The conditional variance of τi |Xi is equal to
k

Var(τi | Xi ) = σi / (1+ ∑ wj).
2

(4.6)

j =1

See supplemental materials 4.7.3 for more details.
4.3.3.2 Estimating wj

To estimate the parameter wj we use a linear regression to estimate sample Xj by
regressing it on the remaining samples, generating a sample vector Yj of predicted values
of Xj. Next, we use an Empirical Bayes approach and equate the posterior expectation
E[τi | Xj ] = Yj . By minimizing the sum
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n

∑

2

(E[τi | wj , xij ] - yij) =

i =1

n

∑

k

∑

( (µi +

j =1

i =1

k

wj xij )/ (1+ ∑ wj ) - yij )2 , we
j =1

find the optimal weight parameter wj, given by:
n

∑

wj =(

(yij - µi )( xij - µi ) ) / (

i =1

n

∑

(xij - yij )( xij - µi ))

(4.7)

i =1

For the proof see supplemental materials in 4.7.4.

4.3.3.3 Testing for differential expression

To test for differential expression we calculate the variance of the posterior expectation
ui:

Var(ui)

k

k

j =1

j =1

σi2 ∑ wj(1+ wj)/ (1+ ∑ wj )2 .

=

(4.8)

For more details on the proof see supplemental materials.
Dividing the expectation ui in (4.6) by the square root of (4.8) we get a z-statistic for
gene i,

ai = (µi +

k

∑
j =1

k

wj xij )/( σi ( ∑ wj (1+wj ))1/2) ~ N(0,1).

(4.9)

j =1

4.3.4 CRAM model: sample-specific variance with different contribution per gene
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CRAM allows genes with different intensity values to have different weights. The ∆
log-intensity values xij in sample j, are first categorized into smaller groups. In order to
obtain more stable weight estimates, genes are categorized into three groups. Genes
within a sample can be categorized into any number of groups but the influence of
outliers on the weight parameters increases with the number of groups. Empirical
analysis with different number of groups showed that three groups were optimal in our
setup.
A sample Xj is sorted such that the highest one third of its ∆ log-intensity values are
assigned to group 1, the middle one third are assigned to group 2 and the lowest one third
are assigned to group 3. Similar to the procedure in section 4.3.3, genes in each group g
from sample j are regressed with their corresponding genes in other samples and a weight
Wgj for group g is estimated. After estimating Wgj for each group, genes in sample j are

assigned a weight from the group to which they belong wij = Wgj. This procedure is
repeated for the other samples where all weights are estimated. Although modeling the
weight for each group in a sample, implies that weights and expected ∆ log-intensity are
not independent, we assume a local-independence in which the weight assigned to a
group is independent from the ∆ log-intensity values in that group.

4.3.4.1 Estimating the gene-specific variance σi

2

The first step to estimate the gene-specific variance σi2 is to calculate si2, the premoderated gene-specific variance across samples given by:
98

2

si =

k

∑
j =1

k

wij(xij-ui) / ( ( ∑ wij) 2

2

j =1

k

∑

2

wij ) /

j =1

k

∑

wij )

j =1

2

Next, we calculate V2, the average of si over n genes,

V2 =

n

∑

si2 / n

i =1

A gene-specific variance moderating factor α, a parameter between zero and one is used
such that the estimate for the moderated variance is given by:

i

= αsi2 + (1- α) V2

(4.10)

For more details in how to estimate α, please see supplemental materials.

4.3.4.2 Estimating the CRAM z-statistic

Extending (4.9) to different weights within samples, a CRAM z-statistic is
estimated for gene i, under the local-independence assumption as introduced in 4.3.4,

i = (µi +

k

∑
j =1

wij xij )/(

k

1/2
i ( ∑ wij (1+wij )) )

(4.11)

j =1

The statistic above is only a standard Normal distribution in ideal situations, when all
underlying assumptions are true. An additional transformation is often required to
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generate more accurate p-values as suggested by (Eaves, Wicker et al. 2002). For more
accurate p-values, we calculate a standardized transformation generating the CRAM zstatistic, given by:

zi = (

i

- average( 1,

2,

…,

n)

) / stdev( 1,

2,

…,

n)

and the two tail p-value is given by
p-value = 2 Φ (-|zi|)

(4.12)

where Φ is the standard normal cumulative distribution function.

4.3.5 Comparison of CRAM against other approaches

We compare CRAM against all other methods using the biological significance of
gene lists identified by each approach. To measure the biological significance of gene
lists, we use enrichment of Gene Ontology (GO) biological process categories
(GeneOntology ; GOTermFinder). The primary assumption is that a more accurate gene
list will have on average, more significant GO categories than a less accurate gene list.
We used an iterative approach to assess biological significance of gene lists from each
approach. In each iteration a subset of k’ samples (k’ = 4 in this paper) is randomly
selected and submitted to each method, which produces a candidate list of differentially
expressed genes of a pre-specified size m. Gene lists are generated by sorting in
descending order by the measure of differential expression of each approach (z-statistic in
CRAM). Next the top m genes are selected into a gene list. We consider gene lists of
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sizes m = 200, 400 and 800 genes. A total of 1000 iterations are performed for each
dataset and for each gene list size.
For each gene list, a p-value is obtained for each GO category using an algorithm
based on GO Term Finder (Boyle 2004). The most significant GO category (smallest pvalue) is selected and its corresponding p-value is stored for each approach and for each
gene list size. After all iterations are performed, the average of the -log(p-value) for each
approach and each gene list size is computed. The average -log(p-value) over all
iterations is used as the measure of biological significance.

4.3.6 Other Versions of CRAM
4.3.6.1 CRAM-binary

This is a robust version of CRAM and was developed to handle datasets with a high
incidence of outliers. Instead of using its original values, all samples Xj are ranked and
categorized as a dichotomous variable. For a detailed description of the algorithm,
please see supplemental materials.

4.3.6.2 CRAM expectation maximization (CRAM-EM)

This is the fastest version of CRAM. It replaces the regression step as in 4.3.3.2 by
assigning initial weights w1, w2,…, wk = 1. In this version, Xj is also estimated using
the remaining samples but instead of using a regression, Xj is estimated using a iterative
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procedure where a weighted average is used. Then Yj , which is the estimate of Xj is
given by
k

Yj

= ( ∑ wlXj ) / (
l ≠ j =1

k

∑

l ≠ j =1

k

k

l ≠ j =1

l ≠ j =1

wl ) where yij = ( ∑ wlxij ) / ( ∑ wl ) .

For a detailed description of the algorithm, please see supplemental materials in 4.7.4.

4.3.6.3 CRAM gene correlation (CRAM-GC)

In addition to capturing associations between microarray samples, this version also
captures associations between genes. The underlying assumption is that since every gene
belongs to the same pathway of another gene, then a differentially expressed gene should
have a strong level of association with at least some other gene. Similarly to correlating
samples, a gene highly correlated with another gene is an indication of confidence in the
expression values of that gene. For this reason, the quantification of gene correlations
will prove to be a significant improvement over all previous versions of CRAM.
CRAM-GC is also computationally very efficient, making it applicable to large
microarray datasets.

4.3.6.3.1 Additional Datasets:

To test the CRAM-GC approach, we used the 4 datasets described in the
beginning of this chapter, and added 3 additional datasets (Gasch, Spellman et al.
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2000; Tu, Kudlicki et al. 2005; Hu, Killion et al. 2007) , named respectively datasets
5, 6 and 7 (Table 1).

Table 1 – Description of the three additional datasets used to measure the performance of
CRAM-GC.
DATASET
5
6
7

Description

Yeast mutant strains
Yeast CEN.PK strain
Yeast mutant strains (transcription
factor deletion)

ARRAY TYPE
Two colors non‐paired
One color non‐paired
time course

#
microarrays
174

Two colors non‐paired

36
269

All of the additional datasets were non-paired, meaning that each sample corresponds to a
specific microarray. Dataset 5 with 174 cDNA microarrays (two colors) is a dataset in
which responses were measured for many different stresses. Dataset 6 with 36
microarrays is an Affymetrix (Affymetrix) type microarray (one color) with a time course
covering three complete cell cycles. In dataset 7 with 269 cDNA microarrays, each
microarray corresponds to a transcription factor deletion (263 non-essential and 6
essential). Dataset 5 and 7 can be considered heterogeneous datasets, whereas dataset 6
is not clearly defined, given that each sample is a biological replicate but at a different
time point, and therefore has higher heterogeneity than a typical biological replicate
experiment, but lower heterogeneity than datasets 5 and 7. An overall description of the
CRAM-GC version is presented next, followed by the algorithm.
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4.3.6.3.2 CRAM-GC linear model:
2

Let xij = τij + eij , where eij ~ N(0, σi /wij), and xij is the gene expression (say
log-intensity or ∆log-intensity) for gene i and sample j, wij > 0 is a weight (or
precision) parameter of gene i and sample j, for a total of k samples and n genes and

τij is an unknown random variable for gene i and sample j, with distribution
N(µij , σi2), where µij is a known prior estimate of τij for gene i and sample j.

4.3.6.3.3 Posterior expectation

As a result, the posterior expectation E[τij | xij] is a Gaussian distribution with
2

mean equal to (µij + wij xij )/(1+ wij) and variance equal to σi /(1+ wij).

4.3.6.3.4 Homogeneous sample weight assumption

In this version, we assume that the weight for every sample is constant within
each sample. A non-constant array (sample) weight can also be used, but since only a
minor improvement in GO enrichment was observed, we will use this assumption for
simplicity. In this version of CRAM, the sample weight for sample j is denoted as aj.
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4.3.6.3.5 Sample-gene weight independence assumption

The cell (gene-sample combination) weight wij can be written as wij = aj gi,
where gi is defined as the gene weight for gene i, under the assumption that the
sample weight aj is independent from the gene weight gi.

4.3.6.3.6 Estimating sample weights aj.

In order to increase computational performance with a very minor loss in
precision, we estimate the sample weights based on the highest correlated sample with
each sample. We first generate a Spearman correlation matrix for all k samples and select
for each sample j the maximum absolute value of the correlation coefficient over all
remaining k-1 samples. Next, we let ρj be the maximum correlation coefficient of
sample Xj and let Xj’ be the sample with maximum correlation with Xj. Next we generate
a predictive value Yj by performing the regression Yj = c Xj’, where c minimizes the loss
n

function L for sample j, given by sum of the squared residuals L =

∑

(xij - c xij’)2.

i =1

Similar to 4.3.3.2, if we let µj be the vector of prior parameters for sample j denoted by
(µ1j, µ2j,…, µnj) and letting Tj = {τ1j,τ2j,…,τnj} be the vector of unknown expectations
for sample j the weight aj is estimated by equating the posterior expectation E[Tj | Xj] =
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(µj + Xj aj)/(1+ aj) = Yj , where aj > 0 is the weight parameter for sample j, we
estimate aj that minimizes the sum

n

∑

(E[Tj | Xj] - Yj )2 , and similar to (4.7) we get

i =1

aj =(

n

∑

(yij - µij )( xij - µi ) ) / (

i =1

n

∑

(xij - yij )( xij - µi )).

i =1

4.3.6.3.7 Estimating gene weights gi.

The next step is to generate a Spearman correlated matrix for all n genes and
select for each gene i the maximum absolute value of the correlation coefficient over
all remaining n -1 genes and call ρi the corresponding correlation coefficient. In
datasets in which the number of samples k are small, given that the number of gene n
is large, a maximum absolute correlation can be a high number just by chance, that is,
under a random scenario.
For example, under a random scenario in which expression values are permuted
within each gene, the maximum correlation between genes can be highly inflated by
chance, leading to the expectation E[ρi] > 0 but most of all, E[ρi] can become close
to one. In order to correct for optimistic gene correlations for datasets of all sizes, we
’

need to deflate each ρi, generating an adjusted ρi which we will call ρi .
The basis of this approach is to test if |ρi| is greater than |ρiR| the maximum
correlation between genes in a random scenario, obtain a p-value, and then use the p-
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value to deflate |ρi|. We should keep in mind that |ρiR| is a random variable, whereas

|ρi| is the observed maximum correlation between gene i and the remaining genes.

4.3.6.3.8 Fisher’s transformation of Spearman’s correlation coefficient

Applying Fisher’s transformation to ρi, which we will call f(ρi), we get

zi = f(ρi) = 0.5(k-3)1/2ln( (1+|ρi| )/( 1- |ρi| ) )
where zi is approximately the absolute value of a N(0,1) under a random scenario.
Let α be the level of significance such that

α = 1/n

z0i = Φ-1(1-α),

and

-1

where Φ represents the inverse of the Normal cumulative distribution function and z0i
represents the standardized z-statistic corresponding to the maximum correlation under
a random scenario with significance level equal to α. Let f

--1

be the inverse function

of the Fisher transformation such that

f--1(z0i) = (exp{2z0i/(k-3)1/2} – 1)/(exp{2z0i/(k-3)1/2} + 1),
and

z1i = z0i + f--1(z0i) (k-3)1/2/2(k-1)
where z1i is the mean of the transformed maximum correlation coefficients
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(mean of f(|ρiR|) ), generated under the random scenario. Finally let zi’= zi – z1i,
which is the distance between zi (the transformed |ρi|) and z1i (the transformed |ρiR|).
Let R be the random variable N(z1i , 1). Then, the likelihood of observing zi in R,
is the density of the conditional distribution P( R | zi) which is N(zi’,1). In order to
avoid negative values for zi’, we set the constraint that zi’= 0, if zi’ < 0. By using the
’

’

inverse Fisher transformation on zi’, we get |ρi | = f--1(zi’), where |ρi | is the adjusted value
for |ρi|, the absolute value of the observed correlation coefficient. After generating the
’

adjusted correlation |ρi | for every gene i, we find the gene weight following similar steps
to estimating the sample weights aj. We regress Xi = {xi1, xi2, …,xik} with the gene with
the highest correlation

Xi’ = {xi1’, xi2’, …,xik’} such that Xi = ciXi’,

where the slope ci minimizes the sum of the squared residuals. Without any adjustment,
ci is given by ρi (σx/ σx’), thus the adjusted ci is given by ρi’ (σx/ σx’), which is equal to
’

the original ci multiplied by the shrinking factor |ρi |/|ρi| and thus each yij from (4.7) can
’

be written as ci|ρi |/|ρi| xij, thus, the weight for gene i is given by

gi = (

k

∑

(ci|ρi’|/|ρi| xij - µij )( xij - µi ) ) / (

j =1

k

∑

(xij - ci|ρi’|/|ρi| xij )( xij - µi )).

j =1

Comment: the adjustment for the sample correlations (estimating aj) was not used

since the number of samples (k = 300) is small compared to the number of genes n
(≈ 6000 for yeast) and therefore it is not necessary to adjust for sample correlation
coefficients. In summary, the main reasons for not adjusting the sample correlation
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coefficients is (a) there are a much smaller number of correlations between samples in
which the maximum is selected, as compared to correlating genes and (b) the sample
vectors are much larger than the gene vectors (n vs. k), making the sample correlation
coefficients much more stable.

4.3.6.3.9 Expected log-intensity of a gene-sample combination.

Since wij = aj gi , after all sample weights and gene weights are estimated, we have
the expected value of the posterior

E[τij | xij] = (µij + xij wij )/(1+ wij).

(4.13)

So if either aj = 0 or gi = 0, this would imply wij = 0, indicating we have no
confidence in our value xij and therefore E[τij | , xij ] = µij, the prior expectation for gene
i.

4.4 RESULTS
4.4.1 Normality assumption

We first assess the extent to which each dataset satisfies the normality assumption.
For all four datasets, a standardized expected ∆ log-intensity value was generated for
every gene by using equation (4.9) which assumes weights are constant within each
sample. Next a histogram of the standardized values was plotted for each dataset (Fig.
1).

In addition, a Kolmogorov-Smirnoff test for normality was used. Dataset 1 had a p109

value < E-300, dataset 2 had a p-value equal to 7.6E-242, dataset 3 had a p-value equal to
1.7E-04 and dataset 4 had a p-value equal to 3.9E-128. These p-values also suggest data
in all four datasets are not normally distributed, although in dataset 3 this can be
attributed to the left tail, since the right tail looks close to Normal.

Figure 1 – Histogram of standardized expected ∆ log-intensity (ui/stdev(ui)) for each
of the four datasets. Histograms for datasets 1 and 2 are very different from the
continuous line (standard Normal distribution). The distribution of standardized values
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in dataset 3 looks Normal, whereas in dataset 4 it has clearly a thicker tail than a
Normal distribution and its histogram is skewed to the right. The result of long tails in
datasets 1 and 2 and to a lesser extent in dataset 4, suggest inflated t-statistics,
originating from the underestimation of gene-specific variances. Also, heavy tails on
datasets 1 and 2 indicate high biological heterogeneity between samples.
4.4.2 Enrichment measures – CRAM

We compared the enrichment of CRAM to four other approaches of identifying
differentially expressed genes. These approaches were two state of the art algorithms for
measuring differential expression, locally moderated t-statistic (LMW), weighted
moderated t-statistic (WAME) and two general algorithms fold change (FC) and tstatistic (t). We also compare against an approach, RANDOM, which generates random

gene lists as a baseline for comparison.
We first considered up-regulated genes that were high in the quiescent population
compared to non-quiescent. CRAM had the highest enrichment for gene list sizes 400 and
800 in dataset 1 (Table 2) and had equal performance, compared to WAME for gene list
size 200.
Table 2 – Enrichment (average -log p-value) for gene lists of different size for each
method. Highest enrichment for each sample size in bold. Standard errors are
approximately 0.25 for all methods excluding RANDOM with SE = 0.04. If the highest
and second highest enrichment are not significantly different, the two enrichment values
are made bold.
DATASET 1 - GO ENRICHMENT 1000 simulations
CRAM

WAME

LMW

FC

t

RANDOM

200

24.84

24.89

22.78

23.3

10.91

6.93

400

37.97

36.97

31.68

31.89

12.52

7.12

800

32.28

31.00

31.23

28.97

16.04

6.88

list size

111

Dataset 2 showed CRAM and WAME as the most enriched and equivalent for all sample
sizes (Table 3).

Table 3 – Enrichment (average -log p-value) for gene lists of different size for each
method. Highest enrichment
for each sample size in bold. Standard errors are
approximately 0.25 for all methods excluding RANDOM with SE = 0.04. If the highest
and second highest enrichment are not significantly different, the two enrichment values
are made bold.
DATASET 2 - GO ENRICHMENT 1000 simulations
list size

CRAM

WAME

LMW

FC

t

RANDOM

200

24.11

24.22

23.85

23.49

15.15

6.92

400

103.71

103.91

85.24

84.5

36.25

6.87

800

84.81

84.65

83.71

76.8

44.95

6.96

In dataset 3, CRAM had the highest enrichment for all gene list sizes (Table 4).

Table 4 – Enrichment (average -log p-value) for gene lists of different size for each
method. Highest enrichment for each sample size in bold. Standard errors are
approximately 0.25 for all methods excluding RANDOM with SE = 0.04. If the highest
and second highest enrichment are not significantly different, the two enrichment values
are made bold.
DATASET 3 - GO ENRICHMENT 1000 simulations
list size

CRAM

WAME

LMW

FC

t

RANDOM

200

13.76

11.56

11.5

10.02

13.04

6.91

400

17.8

15.07

15.91

11.2

14.62

6.97

800

21.61

18.67

20.11

13.4

15.7

7.01

In dataset 4 CRAM had the highest enrichment for gene list sizes 800 and had similar
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enrichment to standard t statistics for sample size 400 (Table 5).
Table 5 – Enrichment (average -log p-value) for gene lists of different size for each
method. Highest enrichment for each sample size in bold. Standard errors are
approximately 0.25 for all methods excluding RANDOM with SE = 0.04. If the highest
and second highest enrichment are not significantly different, the two enrichment values
are made bold.
DATASET 4 - GO ENRICHMENT 1000 simulations
CRAM

WAME

LMW

FC

T

RANDOM

200

70.0

53.37

53.13

26.43

92.5

6.53

400

84.75

74.7

70.41

22.16

85.0

6.97

800

68.59

63.2

61.77

24.07

62.06

6.88

list size

4.4.3 Enrichment measures – CRAM-GC

To measure the results, each sample had its gene enrichment evaluated separately. Given
that some tested datasets are heterogeneous (biologically dissimilar) in which case,
combining samples is of questionable use. Our goal is to measure the improvement in
GO enrichment from every individual sample.
In heterogeneous datasets, standard methods for evaluating the gene-specific variance
σi2, assume a gene-specific variance moderation parameter equal to zero, meaning the
gene-specific variance is constant for all genes. This constant variance assumption has
been shown to produce higher overlap between samples even in homogeneous datasets.
In this sense, we chose to compare GO enrichment of every array using the original fold
change values, compared to CRAM-GC expected fold change using (4.13). Also, the
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sample-specific variance from other approaches is assumed constant within the sample,
meaning that it does not influence the rank order of the genes when selecting for a gene
list using a single sample. Thus, ranking genes from a single sample by their original
fold change values is the equivalent of ranking them by using other common approaches.
The p-value for the most significant GO category for every sample comparing the
original fold change log intensity value with CRAM-GC expected fold change was
calculated, where the corresponding –log(p-value) for the two approaches was averaged
for all samples for each dataset. A one tail p-value for differences of means of between
the two averages of –log(p-value) for CRAM-GC and original fold change was
generated for every gene list sizes of 200, 400 and 800. In addition, a measure of
percentage of times CRAM-GS had superior enrichment compared to the original value
was performed (tables 6 to 12). In all tables CRAM-GC had a significant p-value (<
0.05) for all genes list sizes. When comparing the number of times CRAM-GC had
superior enrichment, CRAM-GC was marginally lower in (Table 6) (gene list size 200)
and (Table 7) (gene list size 400), but superior in all other cases.
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Table 6 – Enrichment (average -log p-value) for gene lists of different sizes for CRAMGC and the original fold change (columns 1 and 2). P-values for differences of means
(over 80 samples) between columns 1 and 2 were generated (column 3). In column 4 we
present the % of times CRAM-GC had superior enrichment to the original fold change
value (in case there were ties, a 0.5 count was assigned to both Original FC and CRAMGC).
DATASET 1 – 80 paired samples
List size

Original-FC

CRAM-GC

p-value diff

% Cram > Orig.

200

18.57

19.15

2.0E-02

45%

400

26.35

34.15

8.7E-10

72%

800

23.24

28.22

2.4E-08

69%

Table 7 – Enrichment (average -log p-value) for gene lists of different sizes for CRAMGC and the original fold change (columns 1 and 2). P-values for differences of means
(over 88 samples) between columns 1 and 2 were generated (column 3). In column 4 we
present the % of times CRAM-GC had superior enrichment to the original fold change
value (in case there were ties, a 0.5 count was assigned to both Original FC and CRAMGC).
DATASET 2 – 88 paired samples
List size

Original-FC

CRAM-GC

p-value diff

200

18.50

19.17

6.8E-03

57%

400

27.62

33.86

2.0E-07

49%

800

26.61

30.66

2.4E-08

56%
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% Cram > Orig.

Table 8 – Enrichment (average -log p-value) for gene lists of different sizes for CRAMGC and the original fold change (columns 1 and 2). P-values for differences of means
(over 16 samples) between columns 1 and 2 were generated (column 3). In column 4 we
present the % of times CRAM-GC had superior enrichment to the original fold change
value (in case there were ties, a 0.5 count was assigned to both Original FC and CRAMGC).
DATASET 3 – 16 paired samples
List size

Original-FC

CRAM-GC

p-value diff

% Cram > Orig.

200

13.35

33.82

1.7E-03

89%

400

13.39

34.37

8.7E-04

98%

800

13.03

28.90

7.6E-04

73%

Table 9 – Enrichment (average -log p-value) for gene lists of different sizes for CRAMGC and the original fold change (columns 1 and 2). P-values for differences of means
(over 10 samples) between columns 1 and 2 were generated (column 3). In column 4 we
present the % of times CRAM-GC had superior enrichment to the original fold change
value (in case there were ties, a 0.5 count was assigned to both Original FC and CRAMGC).
DATASET 4 – 10 paired samples
List size

Original-FC

CRAM-GC

p-value diff

200

6.60

8.84

2.8E-06

90%

400

7.91

9.22

1.2E-03

78%

800

8.07

9.16

3.4E-02

58%
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% Cram > Orig.

Table 10 – Enrichment (average -log p-value) for gene lists of different sizes for CRAMGC and the original fold change (columns 1 and 2). P-values for differences of means
(over 174 samples) between columns 1 and 2 were generated (column 3). In column 4
we present the % of times CRAM-GC had superior enrichment to the original fold
change value (in case there were ties, a 0.5 count was assigned to both Original FC and
CRAM-GC).
DATASET 5 – 174 unpaired samples
List size

Original-FC

CRAM-GC

p-value diff

% Cram > Orig.

200

38.19

50.18

1.2E-07

62%

400

44.54

59.41

1.5E-11

77%

800

50.86

65.47

2.1E-13

79%

Table 11 – Enrichment (average -log p-value) for gene lists of different sizes for CRAMGC and the original fold change (columns 1 and 2). P-values for differences of means
(over 36 samples) between columns 1 and 2 were generated (column 3). In column 4 we
present the % of times CRAM-GC had superior enrichment to the original fold change
value (in case there were ties, a 0.5 count was assigned to both Original FC and CRAMGC).
DATASET 6 – 36 unpaired time course samples
List size

Original-FC

CRAM-GC

p-value diff

200

91.76

93.06

3.6E-02

65%

400

132.50

136.68

1.5E-05

67%

800

138.67

142.17

1.5E-08

79%
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% Cram > Orig.

Table 12 – Enrichment (average -log p-value) for gene lists of different sizes for CRAMGC and the original fold change (columns 1 and 2). P-values for differences of means
(over 269 samples) between columns 1 and 2 were generated (column 3). In column 4
we present the % of times CRAM-GC had superior enrichment to the original fold
change value (in case there were ties, a 0.5 count was assigned to both Original FC and
CRAM-GC).
DATASET 7 – 269 unpaired samples
List size

Original-FC

CRAM-GC

p-value diff

% Cram > Orig.

200

31.00

63.62

4.0E-47

93%

400

29.71

55.71

7.8E-42

91%

800

35.93

59.03

1.1E-53

88%

4.5 DISCUSSION AND CONCLUSION
We have presented the Calibration Regression Analysis of Microarrays (CRAM)
and shown that CRAM had superior performance compared to other approaches. Similar
to existing approaches, CRAM models gene-specific variance as a function of intensity
(Baldi and Long 2001; Sartor, Tomlinson et al. 2006; Fodor, Tickle et al. 2007; Astrand,
Mostad et al. 2008; PLW-Astrand 2008). CRAM improves on existing approaches by
explicitly modeling the dependency between intensity level and sample-specific variance.
The estimation of different sample-specific variances for every gene in each sample was
shown to improve the accuracy in testing for differential expression. In addition, CRAMGC was shown to use effectively the correlation between genes, producing a major
improvement in GO enrichment compared to the standard CRAM model. CRAM-CG
was also shown to be applicable to heterogeneous datasets.
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4.5.1 Overcoming biological heterogeneity

We described in section 4.4.1, the distortions in estimating gene-specific variance in
datasets with high heterogeneity. In datasets 1, 2 and 4, extreme values for the
standardized values of expected ∆ log-intensity indicate a strong underestimation of
gene-specific variance. Our results show CRAM overcomes some limitations of
distortions in gene-specific variance estimates, which are more extreme in heterogeneous
datasets, by finding that the optimal gene-specific variance moderating factor α = 0,
which is equivalent to assuming a constant gene-specific variance. However, estimating
gene-specific variances in heterogeneous datasets based on the expected log-intensity,
will generate underestimated variances resulting in inflated t-statistics, such that gene
lists based on these t-statistics will have inferior enrichment.
Studies have shown that different genes have different variances in expression in
homogeneous datasets (Bar-Even, Paulsson et al. 2006; Wentzell, Karakach et al. 2006).
On the other hand, recent studies have shown than in homogeneous datasets, a higher
concordance between samples is achieved using fold change measures (Shi, Perkins et al.
2008). Curiously, when estimating t-statistics measures in homogeneous datasets,
modeling gene-specific variances based on optimizing for the highest concordance
between samples, often results in sub-optimal GO enrichment. This is still a highly
debatable topic in current literature.
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4.5.2 Gene enrichment performance

Although LMW is an extension of WAME, modeling gene-specific variance as a
function of intensity, WAME performed better than LMW most of the time (Kristiansson,
Sjogren et al. 2005; Bar-Even, Paulsson et al. 2006; Kristiansson, Sjogren et al. 2006;
Wentzell, Karakach et al. 2006; Astrand, Mostad et al. 2007; Sjogren, Kristiansson et al.
2007; Astrand, Mostad et al. 2008). This behavior can be attributed to over fitting of the
gene-specific variance by LMW, due to the non-normality of the distribution of ∆ logintensity values. CRAM, which is similar to WAME with the main difference being the
modeling of sample-specific variance within each sample, is also robust to over fitting of
the gene-specific variance. In general, modeling gene-specific variance as a function of
intensity by CRAM (using groups) proved to be more robust than LMW and at the same
time, generated higher enrichment than WAME, making CRAM biologically accurate
with heterogeneous and homogeneous data.
The enrichment performance of CRAM gene correlation (CRAM-GC) was superior
in every tested dataset, showing that the untransformed fold change values were
significantly less enriched than when gene correlations between genes were taken into
account. This superior enrichment was shown in paired and non-paired designs, in two
and one-color microarrays, in single time point and time course data. However, in order
to fully achieve the benefits of using gene-correlation, it is necessary to have a datasets
with number of samples greater or equal to 10. The primary consequence of using a
sample dataset too small is that correlations will be too unstable with high correlations
being detected as a result of chance (even after Fisher’s transformation adjustment),
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generating a large number of false positive genes, thus resulting in reduced GO
enrichment.
CRAM-applied was also applied to datasets 1 to 4, where most significant GO
enrichment categories for genes higher in Q and similarly for genes higher in NQ (tables
13and 14) were obtained by combing all samples.
Table 13 – Most significant GO categories for gene lists significantly more expressed in
Q than in NQ (p-value < E-6). An additional list was obtained for a sample of size 200
(due to the fact that the gene list based on p-value was not enriched). On the column
named ‘p-value’ we have the p-value for the column ‘# of genes’. On the right hand side
we have the ratio between observed number of genes for GO category and expected
number of genes under the random assumption.

Q Gene lists – Biological Process GO enrichment
DATASETS
Dataset 1

Dataset 2

Dataset 3
Dataset 4

GO category
Ethanol Metabolic
Process
Fermentation
Monocarboxylic Acid MP
Monocarboxylic Acid MP
Amine Catabolic Process
Glucose Catabolic
Process
Pyruvate Metabolic
Process
Glycolysis

# genes

total in
category

sample

p‐
value

ratio
40
30
5
10
65

5
5
22
14
4

11
16
132
132
7

59
59
200
60
60

8.6 E‐
06
7.8E‐05
1.9E‐07
4.9E‐09
5.8E‐05

6

39

64

5.5E‐04

15

13
9

40
22

68
68

7.4E‐15
6.2E‐11

30
35

Table 14 – Most significant GO categories for gene lists significantly more expressed in
NQ than in Q (p-value < E-6). An additional list was obtained of size 200. An additional
list was obtained for a sample of size 200 (due to the fact that the gene list based on pvalue was not enriched). On the column named ‘p-value’ we have the p-value for the
column ‘# of genes’. On the right hand side we have the ratio between observed number
of genes for GO category and expected number of genes under the random assumption.

NQ Gene lists – Biological Process GO enrichment
DATASETS
Dataset 1
Dataset 2
Dataset 3
Dataset 4

GO category
Hexose Trasport
Hexose Trasport
Asparagin MP
Carboxylic Acid MP

#
genes
6
14
6
13

total in category
25
132
39
40
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sampl
e
62
200
58
65

p‐value
2.50E‐05
4.9E‐09
5.5E‐04
7.4E‐15

rati
o
25
10
15
30

Both datasets 1 and 2 shared similar GO categories for both Q (“Monocarboxylic Acid
Metabolic Process”). Similarly for NQ, both datasets shared the same GO categories
(“Hexose Transport”). Dataset 4 most significant GO categories for Q (“Pyruvate MP”
and “Glycolysis”) are subsets of “Monocarboxylic Acid MP”. Curiously, for NQ, dataset
4 most significant GO category was Carboxylic Acid Metabolic Process, which is a
parent category of “Monocarboxylic Acid MP”, suggesting that some genes from the
category Carboxylic Acid may be more highly expressed in Q and others more highly
expressed in the NQ cell population.

4.5.3 Computational speed factors

CRAM was written in MATLAB, and was shown to be highly computationally
efficient, taking an order of magnitude less time, to score the datasets on the same
computer, as compared to other sample-specific variance modeling approaches. The
treatment of each sample as an individual dataset using the framework in (Ibrahim and
Chen 2000), combined with an empirical Bayes approach and measurement error is the
main reason for this efficiency (HerbertR. 1956; Fuller 1987).
4.5.4 Future applications

We intend to apply CRAM to time series microarray data, which can be highly
heterogeneous depending upon the temporal dynamics of the system under study. To
accurately model log-intensity from time series data, CRAM needs to be enhanced to
have gene-specific variance σ2ij for every sample j and for every gene i as opposed to
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using a constant gene-specific variance σi2 for every sample for gene i. More robust
estimation of the weights can be developed where each sample is classified into more
groups. Instead of grouping genes within each sample based on their transformed log
intensity levels, it is possible to group genes using GO biological process categories,
which is likely to better model interactions among genes, leading to improved
performance. Finally, similar experiments can be combined by using each gene’s
expected log-intensity (or ∆ log-intensity) from a previous experiment, as the prior
expected log-intensity in the current experiment.
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4.7 SUPPLEMENTAL MATERIALS
4.7.1 Sample variance distortion in biological heterogeneous datasets

Estimation based on gene sample variance in heterogeneous datasets, can highly
distort the estimation of gene-specific variance, and thus distorts gene-expression
variance estimates. The assumption of a log-intensity expectation τi for each gene i in
estimating gene sample variances, does not hold in the presence of high biological
heterogeneity where each gene i for each sample j, has a more specific (to gene i and
sample j) expectation τij. When assuming a fixed τi for a gene i, the error component for
gene i in sample j, is based on the deviation between τi and xij, whereas the true error
should be based on the deviations between τij and xij. As a result, assuming samples
2

have the same weights, when estimating the gene sample variance si , many approaches
k

assume the true unknown sum of errors across arrays to be

∑

(xij - τi)2 when it should

j =1

k

be

∑

(xij -τij)2. We can write

j =1

k

∑

k

∑

(xij - τi)2 as the sum

j =1

k

∑

(xij - τij)2 +

j =1

j =1

k

( τi - τij)2 - 2 ∑ (xij - τij) (τi - τij) . When true errors are small,
j =1

that is, when xij is close to τij, the third term becomes very small and we have
k

∑
j =1

k

(xij - τi)2 ≥ ∑ (xij- τij)2 , showing an overestimation of the sample variance when
j =1

using an overall ui. On the other hand, when
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k

∑
j =1

k

( τi - τij) < 2 ∑ (xij - τij ) (τi - τij ), we have an underestimation of the variance.
2

j =1

In Fig.1, the observed heterogeneity of datasets 1, 2 and 4, sample variance is
underestimated, suggesting the presence of large errors, where xij is far from τij relative to
the distance between τi and τij. In datasets 1 and 2, underestimation of gene sample
variance was extreme to the point that it was more accurate in some cases, to assume a
homogeneous (constant) gene-specific variance, than modeling gene-specific variance
2

based on the gene sample variance si .

2

4.7.2 Proof: P(τi | xij ) ~ N((µi + wj xij )/(1+ wj) , σi /(1+ wj ) ).

We assume that every gene i for an sample j, has a corresponding random variable τi
2

with distribution P(τi) ~ N(µi, σi ) which has the known prior expectation µi for gene i
and where wj > 0, is an unknown parameter which is constant within sample j,
representing the level of confidence we have in this sample. The parameter wj is also the
inverse of the sample-specific variance defined as 1/wj. Given this, we can write
2

P(xij | τi = λi) = P(eij + τi| τi = λi) = P(eij + λi| τi = λi) ~ N(λi , σi /wj ),
since eij is N(0, σi2/wj )-distributed.
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We pause to recall a convention from Bayesian statistics. If one has two random variables
X and Y, one can write the conditional distribution P(Y|X) as

P(Y|X) = P(X,Y)/P(X) = P(Y)P(X|Y)/P(X).
This is a form of Bayes’ Theorem. Now, we consider 1/P(X) as a constant of
proportionality since X is given and fixed in the conditional probability P(Y|X). Thus,
we can write
P(Y|X) α P(Y)P(X|Y)
where α is the symbol for proportionality (Lee 1997).
By the above discussion, we then have P(τi | xij ) α P(xij | τi) P(τi).
Let Z be a random variable that has the distribution
P(xij | τi = λi) P(τi) ~ N(λi , σi2/wj ) N(µi, σi2)
Then

P(Z = z) = (

1
1
2π σi2 w1/2)exp(– {wj(z– xij)2 + (z– µi )2}/ σi2 } ) which is proportional to
2
2

exp(–

1
{wj z2 – 2wj xij z + wjx2ij + z 2 – 2 zµi + µ2i }/ σi2 } ) =
2

exp(–

1
{ (wj+1) z2 – 2 z (wjxij + µi ) + wjx2ij + µ2i }/ σi2) =
2
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exp(–

1
{ (wj+1)[ z2 + 2(wj xij + µi )/(1+ wj) z+ wj x2ij /(1+ wj) + µ2i /(1+ wj) ]}/ σi2) and by
2

completing the square by adding and subtracting the term (xijwj + µi )2/(1+ wj)2 in the part
of the equation between the brackets, we have

exp(–

1
1
[z– (xij wj +µi ) /(1+ wj)]2 /(σi2/(1+ wj)))exp(– [wjx2ij –(xijwj+µi)2/(1+ wj)]/ σi2).
2
2

Since the second exponential term does not have the term z, it is just a proportionality
factor, thus, we can say the previous expression is proportional to the first exponential
term

exp(–

1
[z– (xij wj + µi )/(1+ wj)]2/ (σi2/(1+ wj)) )
2

which is proportional to a normal distribution with mean (µi + wj xij)/(1+ wj) and
variance

σi2 /(1+ wj ). Thus we can write
P(τi | xij ) α N( (µi + wj xij)/(1+ wj) , σi2 /(1+ wj ) )

and we are done.

k

k

j =1

j =1

k

4.7.3 Proof: P(τi | X) ~ N( (µi + ∑ wj xij )/(1+ ∑ wj ) , σi / (1+ ∑ wj) ).

P(τi | xi1, xi2 , … , xik , w1 , w2 , … , wk ) is proportional to
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2

j =1

P(xi1, xi2 , … , xik | w1 , w2 , … , wk , µi ) P(τi) and by independence between
samples,

P(xi1, xi2 , … , xik | w1 , w2 , … , wk , τi ) is proportional to
P(xi1 | w1 , τi ) P(xi2 | w2 , τi )… P(xik | wk , τi ) and therefore
P(τi | xi1, xi2 , … , xik , w1 , w2 , … , wk ) is proportional to
P(xi1 | w1 , τi) P(xi2 | w2 , τi)… P(xik | wk , τi ) P(τi ) which is the kernel of a Normal
k

k

j =1

j =1

k

distribution with mean (µi + ∑ wj xij )/ (1+ ∑ wj ) and variance σi / (1+ ∑ wj).
2

j =1

This last step can be shown in greater detail if we follow the same steps as in 4.7.2 where
we complete the square and get an expression proportional to

exp( –

k
k
k
1
[ (τi – (µi + ∑ wj xij )/ (1+ ∑ wj ) ]2 / ( σi2 / (1+ ∑ wj) ) ).
2
j =1
j =1
j =1

4.7.4 Estimating wj , the weight parameter of a sample j.

Remembering that Yj = {y1j, y2j, … , ynj} is an estimate of Xj ={x1j, x2j, ... , xnj}, let the
vector

µ

= {µ1 , ... ,µn} be the vector of known prior expectations and denoting

T = {τ1,τ2,…,τn} the vector of unknown expectations, from (4.4) or 4.7.2, we have

E[T | Xj ] = (µ + wj Xj )/(1+ wj ).
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By performing the regression Yj = E[T | Xj ] , we estimate wj which minimizes the loss
function Lj, denoted as the sum

n

∑

((µi + wj xij )/(1+ wj) - yij )2 , we set the derivative

i =1

∂ Lj / ∂ wj = 0, and thus

n

∑

2((µi + wj xij )/(1+ wj) - yij )( xij - µi )/(1 + wj)2 = 0 .

i =1

Since the term (1+wj)2 is constant throughout sample j, we can simplify the equation by
making

n

∑

((µi + wj xij )/(1+ wj) - yij )( xij - µi ) = 0 .

i =1

Thus, solving for wj we get

wj = (

n

∑

(yij - µi )( xij - µi ) ) / (

i =1

n

∑

(xij - yij )( xij - µi )).

(4.7)

i =1

4.7.5 CRAM algorithm

We present the CRAM algorithm where the CRAM z-statistic is calculated.
/*Calculation of weights wij, for all n genes, k samples and g groups per sample.*/
for each sample j:

1- Group genes into three groups using their intensity values, by sorting in
descending order by xij
for each group g:
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a. Perform a linear regression where Xj ={x1j, x2j, ... , xnj}is estimated using
the remaining set of Xl where l ≠ j , generating a set of Yj = { y1j, y2j, … ,
ynj} predicted values.
n

n

i =1

i =1

b. Calculate Wgj = ( ∑ Ig(yij - µi)( xij - µi))/( ∑

Ig(xij - yij)( xij - µi)) ,

where Ig is the indicator function for a gene belonging to group g.
end loop

c. For every gene i in array vector j, assign the weight wij = Wgj.
end loop

/*Calculation of z-statistic*/
for each gene i:

1- Get the estimate ui for the unknown expectation τi:

ui = (µi +

k

∑
j =1

k

wij xij )/ (1+ ∑ wij)
j =1

2- Calculate the weighted sample variance:

si2 =

k

∑
j =1

k

wij(xij-ui)2/ ( ( ∑ wij)2 j =1

k

∑
j =1

2

3- Calculate the average of all si :

V2 =

n

∑
i =1
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si2 / n

wij2) /

k

∑
j =1

wij )

4- Use optimal α and estimate the gene-specific variance:

i

5- Generate the estimate for

2

= αsi2 + (1- α) V2

i

i= (µi +

k

∑

k

wij xij )/(

∑

i

j =1

n

6- Calculate

i_m

=∑

i/

wij (1+ wij) )1/2

j =1

n and S = (

i =1

n

∑

(

i–

i_m

)2/(n-1) )1/2

i =1

7- Generate the CRAM z-statistic, which is approximately N(0,1):

zi = (

i

-

i_m)/S

A two tail p-value for each gene can be generated by 2Ф(-|zi|), where Ф is the
standard Normal cumulative distribution function.
end loop

4.7.6 Estimating the variance of the posterior expectation ui

To calculate the variance of the estimated expectation ui, we have

Var(ui) = Var((µi +

k

∑
j =1

k

wj xij )/ (1+ ∑ wj ) ) =
j =1

By (4.1) and (4.2) variance of xij is given by
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k

∑
j =1

k

w j Var(xij )/ (1+ ∑ wj )2 .
2

j =1

Var(xij) = Var(τi )+ Var(eij) = σi2 + σi2/ wj = σi2 (1+ wj)/ wj and thus
Var( (µi +

k

∑
j =1

k

k

k

j =1

j =1

j =1

wj xij )/ (1+ ∑ wj ) ) = σi2 ∑ wj(1+ wj) / (1+ ∑ wj )2

(4.8)

4.7.7 Optimizing the α parameter

In this paper, we will set α = 0.9 for homogeneous datasets (datasets 3 and 4) and α = 0
for heterogeneous datasets (datasets1 and 2). This criterion for selecting α is used to
generate the CRAM z-statistic in (4.11) which is used for generating lists of size 200, 400
and 800. We present two methods to estimate α.
4.7.8 α estimation for the whole dataset (Method 1)

The main assumption is that the α which best models the upper tail of a true N(0,1), is the
α that best moderates the gene-specific variance. We chose the 90th percentile (q = 0.90)
to define the upper tail, although other values could be used as well. An individual α is
optimized for each dataset.
For every simulated α = 0, 0.1, 0.2,…, 0.9, 1.0.

1. Estimate ui for every gene i, using equation (6)
2. Estimate σi2 for every gene i using equation (10).
3. Generate the z-statistic ai by (9).
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4. Generate a’i = ai – {mean of ai over all n genes}.
5. Sort in descending order by a’i.
6. Select a’i corresponding to the 90th percentile. Call this a’90th.
7. Generate p90th = Ф(-|a’90th|) where Ф is the Standard Normal cdf.
8. Calculate ∆(α) = | p90th – (1 – q) | = | p90th – 0.10 |.
End loop

Select α that generates the smallest ∆(α) for all simulated values of α .

4.7.9 α estimation for each simulated sample (Method 2):

If the research conducting the microarray experiment has a small dataset (small number
of samples), this method will be more appropriate than method 1. In order to estimate α,
the dataset is divided into test data and hold out data. The main assumption is that the
optimal alpha is the one that has the highest overlap between the test data (Test) and the
hold out data (Ho).
For every simulated l = 1,…,11

Let α = 0.1(l-1)
For each sample j = 1, …, k

1. Select array j as the hold data. Select the remaining arrays as test data.
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2. Use the weight wj of sample j, to estimate the expectation of the hold out data.
Ho_ui = (µi + wj xij)/(1+ wj)
3. Use the weights excluding wj to estimate the expectation of the test data.

Test_ui = (µi +

k

∑

l =1≠ j

k

wil xil )/ (1+ ∑ wil)
j =1

2

4. Estimate si for every gene i in the test data.

si2 =

k

∑

l =1≠ j

k

wil (xil - Test_ui)2/ ( ( ∑ wil)2 l =1

k

∑
l =1

wil2) /

k

∑

wil )

l =1

2

5. Calculate the average of all si in the test data:

V2 =

n

∑

si2 / n

i =1

2

6. Estimate σi for every gene i in the test data using the simulated α.

i

2

= αsi2 + (1- α) V2

7. Standardize the expectations of the hold out data and test data by dividing by
σi_hat.
Test_ti = Test_ui /
Ho_ti = Ho_ui /
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i

i

8. Sort both Test_t and Ho_t in descending order.
9. In both sorted Test_t and Ho_t , select for the top C genes.
10. Count the number of overlapping genes after selection between Test_t and Ho_t,
and call this Pre_overlap(l , j).
End loop

11. Get the mean of the Pre_overlap(l , j) over all j. Call this Overlap(l).
End loop

12. Set pos = Argmax(Overlap).
13. Optimal α is equal to 0.1(pos-1).

4.7.10 Other versions of CRAM
4.7.10.1 CRAM-binary

This is a robust version of CRAM and was developed to handle datasets with a high
incidence of outliers. Instead of using its original values, all samples Xj are ranked
and categorized as a dichotomous variable.

4.7.10.2 CRAM expectation maximization (CRAM-EM)

This is the fastest version of CRAM. It replaces the regression step in 4.3.3.2 by
assigning initial weights w1, w2,…, wk = 1. In this version, Xj is also estimated using
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the remaining samples but instead of using a regression, Xj is estimated using a
iterative procedure where a weighted average is used. Thus Yj , the estimate of Xj is
the vector denoted by (y1j , y2j , … , ynj ), where yij = (

k

∑

l ≠ j =1

k

wlxij ) / ( ∑ wl ) .
l ≠ j =1

4.7.11.2 CRAM-EM Algorithm

1- Assign initial weights w1, w2, …, wk = 1.
For every iteration until convergence of the weights
For every sample j

2- Estimate Yj using the current weights, such that
k

k

l ≠ j =1

l ≠ j =1

yij = ( ∑ wlxij ) / ( ∑ wl ).
3- Estimate a new weight for sample j such that

wj =(

n

∑

(yij - µi )( xij - µi ) ) / (

i =1

n

∑

(xij - yij )( xij - µi )).

i =1

Assuming negative weights are not possible, if wj < 0 we make wj = 0.
End loop

4 - Update all weights w1, w2, …, wk .
5- If convergence then end.
End loop
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Once the weights are defined, the rest of the procedure is identical to CRAM. The as the
number of samples increase, the EM procedure becomes much faster than using a
multiple linear regression, with the same performance.

4.7.11.3 CRAM-binary algorithm

Define γ, a cutoff value such that 0 ≤ γ ≤ 1.
For every sample j
Sort each Xj in ascending order and define Vj = {v1j , v2j , …, vnj } where

vij = 1 if xij is in the top γ proportion of the total number of genes and vij = 0
otherwise.
End Loop

As a result Vj will have approximately γ values equal to 1 and 1 – γ values equal to 0.
1- Assign initial weights w1, w2,…, wk = 1.
For every iteration until convergence of the weights
For every sample j

2- Estimate Yj using the current weights Yj such that
Yj = (1 +

k

∑

l ≠ j =1

k

wl Vj ) / (1/γ + ∑ wl ).
l ≠ j =1
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3- Estimate a new weight wj for sample j such that

wj = 1 − γ Cov(Yj , Xj )/(Var(Xj ) – Cov(Yj , Xj )).
γ

Assuming negative weights are not possible, if wj < 0 we set wj = 0.
End loop

4 - Update all weights w1, w2, …, wk .
5- If convergence then end.
End loop

6- Generate the final estimate ui for every gene given by
k

k

j =1

j =1

ui = (1 + ∑ wj vij ) / (1/γ + ∑ wj ). Note: if prior probabilities πi are known,
then

k

k

j =1

j =1

ui = (1 + ∑ wj vij ) / (1/πi + ∑ wj ).

4.7.11.4 CRAM-GC algorithm

1. Generate a Spearman correlation matrix with all samples.
For every sample j

2. Select the maximum correlation ρj among all the remaining samples.
3. Generate the sample weight aj is given by
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aj =(

n

∑

(yij - µij )( xij - µi ) ) / (

i =1

n

∑

(xij - yij )( xij - µi )).

i =1

End loop
For every gene i

4. Generate a Spearman correlation matrix with all genes.
5. Select the maximum absolute correlation |ρi| among all the remaining genes.
6. Use the Fisher’s transformation to get a corresponding zi statistics

zi = f(ρi) = 0.5(k-3)1/2ln( (1+|ρi| )/( 1- |ρi| )
-1

-1

7. Let α = 1/n be the level of significance and let z0i = Φ (1-α), where Φ
represents the inverse of the Normal cumulative distribution function.
--1

1/2

1/2

8. Let f (z0i) = (exp{2z0i/(k-3) } – 1)/(exp{2z0i/(k-3) } + 1)
--1

1/2

9. Let z1i = z0i + f (z0i) (k-3) /2(k-1).
10. Let zi’= zi – z1i. If zi’ < 0 then set zi’ = 0.
’

--1

11. By using the inverse Fisher transformation on zi’, generate ρi = f (zi’).

12. Generate the gene weight given by

gi = (

k

∑

(ci|ρi’|/|ρi| xij - µij )( xij - µi ) ) / (

j =1

k

∑
j =1

End loop
For every array j
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(xij - ci|ρi’|/|ρi| xij )( xij - µi )).

For every gene i

13. Generate the sample-gene weight wij = aj gi.
14. Generate E[τij | xij] = (µij + wij xij ) /(1+ wij ).
End loop
End loop
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Chapter 5 - DISCUSSION

5.1 KEY IDEAS
The studies presented in the previous chapters describe applications in genomics
of three key ideas: concordance, association and multi-dimensional differential
expression. For each of them we have presented applications that identify differentially
expressed genes in a computationally efficient way. In chapter 2 a general framework
was described in which concordance was used to obtain the significance of multidimensional gene list overlaps. In chapter 4, CRAM models were developed where
concordance and association concepts were combined to generate superior measures of
differential expression in unsupervised data. In these models, variance in gene
expression was estimated within and between samples, and was applied to heterogeneous
and homogeneous datasets. In chapter 3 we described the SDI approach, which models
differences in fluorescence intensity in multiple dimensions in order to detect
heterogeneous cell populations in a high-throughput flow cytometry experiment.

5.2 GENE LIST OVERLAPS
The novel method to estimate the significance of gene list overlaps described in
chapter 2 expands on the currently used GO term Finder application (GOTermFinder ;
Boyle 2004) by estimating the significance of overlaps between multiple sets of genes.
An example was described in figure 4, where two gene lists were combined with the set
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of genes belonging to the ‘unknown’ GO category, in which the triple overlap was highly
significant. One immediate application of this method is in the identification and
classification of candidate genes into either a new GO category or a previously known
one. In addition, we have shown that when measuring the significance of overlaps
among three or more sets of genes, the order in which successive pairwise overlaps are
obtained, is critical, resulting in a different p-value for each different order. Another
way to measure the significance of higher order overlaps would be to apply
multidimensional hypergeometric distributions (Kerov 2005), however, we have shown
the limitations of this method since it limited to a single type of higher-order overlap
(assuming independence among all sets), and thus, it is likely to miss some important
lower-order overlaps, that are key to identify the optimal overlap. Based on the
preliminary results in chapter 2, we hypothesize that important biological interactions can
be detected and easily interpreted by using the method we developed.

5.3 CONCORDANCE AND MEASURES OF DIFFERENTIAL
EXPRESSION

5.3.1 Limitations of standard t-statistics

Standard t-statistics applied to microarrays are based on assumptions that are
often violated. The normality assumption of the expected fold change for each gene
often does not hold due to large distortions in the tails of the distribution in most datasets
(Fodor, Tickle et al. 2007). In order to improve the standard t-statistics, several
variations of moderated t-statistics have been developed in which the variance in intensity
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level for each gene is smoothed using highly sophisticated computational procedures
applied to supervised data (Smith 2004; Kristiansson, Sjogren et al. 2005; Kristiansson,
Sjogren et al. 2006; Astrand, Mostad et al. 2007; Astrand, Mostad et al. 2008) .
Nevertheless, even moderated t-statistics often produce gene lists with lower
reproducibility compared to genes lists generated using fold change. In order to
maximize concordance between samples, we described a procedure in which t-statistics is
moderated so that concordance between gene lists is maximized.

5.3.2 Concordance and moderated t-statistics

Most of the currently used moderated t-statistics moderation algorithms have been
developed for supervised datasets where a dependent variable is present. In these
algorithms a variance moderation parameter is optimized in such a way that the
moderated t-statistics best predicts the dependent variable. Since our datasets are all
unsupervised, we had to find alternative ways to moderate gene-specific variances.
In chapter 4 we have presented an algorithm that moderates the variance such that
the average concordance between samples is optimized. As expected, the optimal
variance moderating parameter was equal to zero for all heterogeneous datasets tested,
which implies that the moderated t-statistics has the same rank ordering as fold change.
On the other hand, even in the homogeneous datasets (3 and 4), the variance moderating
parameter was equal to zero, confirming the assumption that optimal concordance is
reached by using fold change measures (Shi, Perkins et al. 2008).
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5.3.3 Concordance vs. GO enrichment

Fold change and t-statistics (moderated or not) are the two most common methods
to evaluate differential expression. As described in detail by (Tusher, Tibshirani et al.
2001; Shi, Tong et al. 2005; Tu, Kudlicki et al. 2005; Shi, Reid et al. 2006; Shi, Perkins
et al. 2008) when using biological replicates to measure concordance between gene lists,
fold change is almost always superior to standard t-statistics and similarly to moderated tstatistics. However, although fold change is more likely to generate a higher
concordance than a t-statistics, we should ask the question: Does a higher concordance
imply in a higher GO enrichment? Preliminary results show that although a hypothetical
gene list A can have a lower concordance than a gene list B, gene list A can have higher
GO enrichment than gene list B. An example using microarray data, can is described in
chapter 4 (tables 4 and 5) where biological replicates were used. In both tables, superior
enrichment was observed for gene lists generated using standard t-statistics when
compared to fold change, although when using t-statistics, concordance between samples
was inferior to fold change. Another example was observed using flow cytometry data,
where the gene list generated using SDI had a much higher GO enrichment than the gene
list generated using average fold change, even though SDI samples had slightly lower
concordance. Based on these findings, we hypothesize that concordance is more suited
to detect measurement or experimental variability rather than biological variability. The
fundamental idea behind this is that if biological differences exist between samples, we
can always increase concordance by using a transformation which smooth’s the original
data. However, we should also keep in mind that by performing this type of smoothing
transformation, we may also be losing valuable biological information. This is the case
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when extreme values in gene expression are biologically accurate, and smoothing the
data will have the effect of down weighting these values, resulting in inferior GO
enrichment.

5.4 ASSOCIATION AND SAMPLE WEIGHT ESTIMATION
Another concept of concordance is based on the idea that gene expression
measurements in a sample are more reliable when the sample has a high reproducibility
with respect to at least one of other remaining samples in a set. In chapter 4, in addition
to the previously described methods to estimate gene-specific variances, we also
described some of the challenges of modeling sample-specific variances in unsupervised
datasets by estimating sample weights. To estimate sample weights two important
concepts were used: linear association and concordance.

5.4.1 Linear association between samples – CRAM model

Sample weights were estimated using the CRAM algorithm, in which association
between samples was identified. To measure these associations, samples were regressed
with remaining samples, generating a predicted log-intensity for every sample. A sample
weight is thus, a measure of association between observed and predicted log-intensity for
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that sample. In CRAM, the weight of a sample was estimated by applying a
transformation such that the sum of square of the differences between predicted logintensity and transformed observed log-intensity was minimized. This concept of
estimating sample weights based on a linear regression was further extended to subgroups of genes within each sample. A general framework was also presented assuming
a known prior expected log-intensity for every gene.
Results in heterogeneous datasets 1 and 2, showed that the WAME method, which
has constant weights within each sample but different weights among samples and is
supervised method similar to the basic version of CRAM, had significant improvement in
GO enrichment when compared to fold change (which assumes all sample weights are
equal). This underlines the importance of modeling sample-specific variances as a way
to detect more accurate biological patterns. Moreover, when WAME was compared to
CRAM, results in datasets 1, 3 and 4 showed CRAM with a marginal but significant
improvement in GO enrichment, stressing the importance of modeling sample-specific
variances within each sample, which is a main characteristic of the CRAM method.
Estimating optimal sample weights is highly dependent on the dataset. Our
results show that sample weight estimation is highly dependent on the level of
homogeneity between samples and will tend to perform better in homogeneous than in
heterogeneous data. The primary reason for this is that when large biological differences
are present among samples, sample weights will usually be underestimated, since the
CRAM model will interpret incorrectly that biological discrepancies among samples, are
the result of noise (measurement error), rather than biological variability. Nevertheless,
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in practice, when CRAM was applied to heterogeneous datasets and datasets using
biological replicates (homogeneous datasets), it generated superior GO enrichment to all
other methods in datasets 1, 3 and 4, and was at least as good as WAME in dataset 2.
Based on these findings, we hypothesize that CRAM is more accurate from a
theoretical perspective, in experiments in which technical replicates are used, since
biological replicates from homogeneous datasets can have high biological variability to
the point that weights can be distorted just as in heterogeneous datasets. Thus, in order to
optimally model biological variability in both heterogeneous and homogeneous datasets,
we developed CRAM-GS, which incorporates correlations between genes into the
measure of differential expression.

5.4.2 Concordance between samples – CRAM BINARY model

A robust version of CRAM (CRAM BINARY) was developed where
concordance was used to estimate the weight of each sample. Samples that had a high
concordance with at least some other sample in the dataset were more heavily weighted
whereas samples that had low concordance with all remaining samples were down
weighted. This use of concordance for weight estimation provides a robust measure of
reproducibility between samples even when log-intensity values deviate largely from a
Normal distribution. Preliminary results comparing CRAM BINARY to fold change,
generated superior GO enrichment in most cases.
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5.5 LINEAR ASSOCIATION BETWEEN GENES
Another novel model called CRAM gene correlation (CRAM-GC), was
introduced in chapter 4, implementing an adjusted Spearman rank correlation between
genes and improving on a recent work where gene correlations were modeled, but
without any adjustment (Leek and Storey 2008). The main assumption is based on the
fact that genes more highly correlated with other genes are likely to be enriched,
compared to uncorrelated genes. One of the main reasons for improvements in GO
enrichment in CRAM-GC derives from the adjustment of rank correlations over all genes
in order to correct for optimistic correlations.
CRAM-GC when compared to fold change showed significant improvement in
GO enrichment in both homogeneous and heterogeneous datasets, in one and twochannel microarrays, and in paired and non-paired designs. In CRAM-GC, rank
correlation between genes was used as an extension of the concept of reproducibility,
with the main advantage that any two genes do not need to be very similar in gene
expression (log-intensity) in order to have a high association, and only need to have a
high rank correlation. Gene weights and sample weights were combined in the CRAMGC model, such that if a gene was not highly correlated with any other gene, the weight
for that gene would be close to zero. Thus, the expected fold change for that gene would
be close to zero, resulting in the gene not being differentially expressed. This down
weighting of genes that had low correlation with all remaining genes is hypothesized as
the main reason for the major improvement in GO enrichment. We further hypothesize,
that this improvement in GO enrichment, results from the fact that if a gene belongs to a
particular GO category, then it is very likely to be highly correlated with at least another
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gene in the same GO category. This makes sense from a biological perspective, since a
gene in the same GO category is very likely to belong to the same pathway of at least
another gene in the same GO category, and thus is expected to have some level of
statistical dependence, resulting in both genes being significantly correlated.

5.6 CRAM: FUTURE WORK
CRAM gene correlation (CRAM-GC) is the most powerful version of all the
CRAM models, due to the high level of biological information obtained from
incorporating gene correlations into the estimation of measures of differential expression.
One potential improvement of CRAM-GC would be to group genes by GO category and
perform gene-correlations restricted to genes within each GO category, generating a
measure of differential expression for every gene and for every GO category. This
potential improvement of CRAM-GC would be feasible as long as GO categories have a
reasonable size (≥ 20 genes). This type of restriction by GO category, would generate
much smaller gene correlation matrices, and would potentially increase biological
accuracy by reducing the number the false positive genes resulted from high correlations
between genes, which sometimes appear even after the adjustments based on Fisher’s
transformation.
The flexibility of CRAM models makes them highly applicable to some of the
latest technologies in transcriptomics such as “Whole Transcriptome Shotgun
Sequencing”, which aims at measuring RNA content (Morin, Bainbridge et al. 2008). In
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microarrays, CRAM models can also be easily adapted to one-channel datasets in which
multiple probes are used for every gene. Moreover, it can be also applied in flow
cytometry datasets such as SDI measures. Finally, CRAM can use prior knowledge for
every gene, generated as outputs from similar experiments, together with the data from
the current experiment in order to improve GO enrichment results.

5.7 DETECTION OF HETEROGENEOUS CELL POPULATIONS –
SLOPE DIFFETENTIAL IDENTIFICATION (SDI)
In order to identify heterogeneous cell populations, we have described in
chapter 3 the method Slope Differentiation Identification (SDI), which was shown to
have superior performance in GO enrichment compared to other methods. SDI also
exhibits a high overlap with our gold standard gene list (gene lists obtained from
stationary two peak distributions). Validation via microscopy also indicated that SDI
was superior in differentiating between quiescent (Q) and non-quiescent (NQ) cell
populations in stationary phase cultures. Moreover, SDI was shown to be highly
computationally efficient taking only a few seconds to score the whole Green
fluorescence protein (GFP) dataset.

5.7.1 Multi-dimensional fold change

SDI is an extension of the concept of fold change in log-fluorescence intensity
between two conditions, in a sense that it is applied to multiple dimensions. In the flow
experiment described in chapter 3, SDI had two additional dimensions besides
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fluorescence intensity: side-scatter and forward-scatter. These two additional dimensions
were used as control variables, where averages of fold change of log-fluorescence
intensity were evaluated for different levels of side-scatter and forward-scatter.
Although recent studies have used clustering methods to model multi-dimensional
flow datasets, these are not optimized to model differences between two conditions in
multiple dimensions (Zeng, Pratt et al. 2007; Pedreira, Costa et al. 2008). The modeling
of the differences in log-fluorescence intensity between stationary and exponential phase
cultures, controlled either by side-scatter or forward-scatter, was shown to add
discriminatory power in accurately detecting heterogeneous cell populations. One of the
advantages in modeling the differences in log-fluorescence intensity between two
conditions rather than modeling each condition separately is that differences in logintensity provide a highly simplified model for every GFP-fusion strain. Another reason
in modeling differences in fluorescence intensity comes from the strong association
between conditions, for a given GFP-strain, and therefore noise levels of the predicted
values from the model, are largely reduced. This same procedure can be extended to
more dimensions, in which case, each dimension would be used as a control variable
whereas the differences in log-fluorescence intensity would be the dependent (or
explanatory) variable.

5.7.2 Modeling SDI using multi-dimensional flow data

Defining the correct binning of a control variable is a crucial step for modeling
multi-dimensional differences in log-fluorescence intensity. Although the fluorescence
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intensity is measured for every cell (event), differences in log-fluorescence intensity can
only be measured for a group of events. In this case, groups are defined based on
different ranges of a control variable (side-scatter or forward-scatter in our experiment).
This grouping procedure may be applied simultaneously to a set of multiple control
variables and their respective ranges, where the average of the difference in logfluorescence intensity between two conditions is estimated for each group.
An improvement of SDI to handle multi-dimensional data would be to generate a
regression tree for every GFP, combining the most important control variables in which
branches and nodes would be selected based on the most significant differences in
average log-fluorescence intensity between two conditions. The output of such trees for
every GFP would produce nodes with various levels in differences in log-intensity (fold
change), where large variations in fold change between nodes, such as high average fold
change for some nodes and low average fold change for other nodes, which would be
indicative of the presence of heterogeneous cell populations.

5.7.3 Modeling SDI with multiple conditions

In chapter 3 it was shown that the pairing between stationary and exponential
phase was necessary in order to calculate the differences in log-fluorescence intensity,
controlled by either side-scatter or forward-scatter. This pairing requirement is essential
when testing for multiple conditions, where fold change between each pair of conditions
is modeled. This approach may be applied to time course experiment in which every two
consecutive time points are treated as two different conditions. Moreover, we can extend
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the concept of differences between two time points using experimental design contrasts in
which three or more time points are used. This would allow h
igher order differences to be calculated, such as acceleration in fold change.

5.7.4 Limitations of concordance between samples

Although concordance between samples in a dataset is a strong indicator of
confidence in data reproducibility, it is not always an indication of optimal enrichment.
For example, in the flow dataset, average fold change had an average concordance
between samples equal to 73% vs. 63% for SDI, whereas the enrichment for SDI was
clearly superior to average fold change. As an example, the overlap between AFC list
and the gold standard stationary SPV list was only 31% (46/147), whereas the overlap
between SDI list and SPV list was 65% (96/147). Recent studies suggest that in order
for biological knowledge to be inferred from the data it is necessary that we have
reproducible samples (Shi, Perkins et al. 2008). However, as our examples show, having
optimal reproducibility between samples does not imply that the approach is optimal to
detect the main biological relationships we are interested in, which was also the case for
SDI. Therefore, the most accurate statistical approaches are likely to have both: highly
reproducible samples and significant GO enrichment.
With the large increase in the amounts of data generated from recent technologies
such as flow cytometry, we expect that future improvements in SDI will be suited for
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disease studies such as Cancer, and to better understand important biological relations,
which result from identifying heterogeneous cell populations. In addition, we expect that
further development of the CRAM methodology, will combine datasets from similar
experiments to generate more biological accuracy. Finally, given the increase in number
of dimensions in flow data (approximately 30 dimensions in the next few years) and
further improvement in gene annotations to GO categories, we believe there is a huge
potential for developing methods that optimally model biological relations.
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